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ABSTRACT
MOLECULAR CHARACTERIZATION OF A CYTOTOXIC-PORIN 
PROTEIN FROM CAMPYLOBACTER JEJUNI AND ITS 
ROLE IN CAMPYLOBACTERIOSIS
by
David J. Bacon 
University o f New Hampshire, May, 1997.
Campylobacter jejuni is a major cause o f enteritis in developed and developing 
countries. A  cytotoxic complex was isolated from organism-free filtrates o f broth grown 
organisms by screening for activity in HEp-2 cells following high performance liquid 
chromatography using a combination of size exclusion and DEAE column 
chromatography. The toxin was found to coincide with a 45 kDa protein possessing an 
N-terminus sequence indicative of a bacterial outer membrane porin protein together with 
a high molecular weight carbohydrate which was determined to be lipopolysaccharide 
(LPS).
The carbohydrate portion of the LPS had reactivity for the lectins Galanthus 
nivalis agglutinin, MaaJda amurensis agglutinin and Datura stromonium agglutinin The 
cytotoxicity o f  the porin-LPS complex was heat-labile at 70 ° C within 30 min. It was also 
found to be resistant to trypsin and to degradation by the enzymes neuriminidase and 
glycosidase F as well as to oxidation with sodium meta-periodate. The complex induced 
DNA fragmentation, cytoplasmic blebbing and nuclear condensation in HEp-2 cells alter 
24 h o f intoxication possibly indicating that the cells were becoming apoptotic.
x
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Oligonucleotides were generated from the N-terminus of the porin protein. Using 
a combination o f vectorette and inverse polymerase chain reaction (PCR) and cloning, a 
1.45 kb fragment was sequenced and found to contain a 1275 base pair (bp) open reading 
frame (ORF). The ORF, designated porA encoded a 424 amino acid protein with a 22 
residue leader sequence and had a calculated molecular weight o f 45.6 kDa and pi o f 4.44. 
The mature protein was 402 amino acids in length and had a molecular weight o f 43.5 kDa 
and a p i o f 4.35. The translated PorA protein had a 50% sequence homology with 
Haemophilis influenzae major outer membrane protein P2. Thirty-two strains of 
Campylobacter sp. and closely related organisms were screened for the porA gene and 
expression o f  cytotoxin in cell culture. Although all strains examined produced a 
cytotoxin, 21 of the 32 strains (66%) were genotypically positive for porA and of these 21 
of 23 (91%) were C. jejuni strains. It is postulated that this cytotoxic protein is a major 
virulence factor for C. jejuni and may be responsible for the clinical symptoms usually 
associated with campylobacteriosis.
xi
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SECTION I
A Historical Perspective of the Genus Campylobacter and 
Campylobacteriosis.
1.1 History of campylobacteriaceae.
la  1913 when bacterial taxonomy was primarily based on phenotypic 
characterization, Mcfadyean and Stockman classified a previously unknown organism 
isolated from an aborted ovine fetus as a " F/'Z»r/o"-like bacterium (228.254). The 
designation was based on the morphology o f the organism at the time it was first isolated. 
Later that same decade, spiral bacteria were again identified in an aborted bovine fetus by 
Smith (233) who named the organism Vibrio fetus. It was his belief that the organism he 
found was the same as the one previously described in 1913. Two more vibrio-like 
organisms, V fetus subsp. venerealis and V. fetus subsp. intestinalis were discovered 
subsequently and linked to fertility problems in cows and ewes respectively (70). These 
microorganisms have since been reclassified and are now formally recognized as 
Campylobacter fetus subsp. venerealis and C. fetus subsp. fetus.
In 1927, the microbiologists Smith and Orcutt (234) were the first to document 
the presence o f vibrio-like organisms in the feces of cattle with diarrhea. Further 
investigations in 1931 by Jones (111) showed that there was a significant correlation 
between bovine dysentery and the presence o f these microaerophilic vibrios. These 
organisms were to become known as Vibrio jejuni (112) and similar bacteria were also 
found in the blood o f patients with diarrhea (125) and aborted sheep fetuses (28). In 
1943, another vibrio was isolated from pigs with diarrhea by Doyle and the organism was
l
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categorized as Vibrio coli (58). Several additional Vibrio species including V. sputorum,
V. bubulus and V faecalis, were isolated and classified according to morphological 
characteristics and a name assigned representative o f the site at which they were first 
isolated. Specifically, V sputorum was isolated from a patient with bronchitis (251), V. 
bubulus from the preputial cavities o f cattle (195) and V. faecalis from sheep feces (195).
It was not until 1963 that researchers took a less descriptive approach to 
classifying the vibrios which had been isolated from symptomatic humans and animals. It 
was already known that the new vibrio-like organisms were microaerophilic, a feature not 
common to other Vibrio sp. In addition, the % Guanidine/Cytosine (%GC) content in the 
deoxyribonucleic acid (DNA) o f the new strains was found to be between 29-36 mol % 
while classic Vibrio sp. have a much higher %GC in the range of 40 to 53 mol % (253). 
Furthermore, the newly discovered “vibrio-like” organisms were unable to ferment 
carbohydrates present in bacteriological media, a characteristic which is not common with 
other o f Vibrio sp. (254). In view o f these traits, Sebald and Veron reclassified V. fetus 
and V bubulus into a newly defined genus referred to as Campylobacter, the Greek word 
for curved rod (228). Veron and Chatelain (254) undertook a more comprehensive study 
in which they reclassified Vibrio jejuni, V sputorum, V coli, and V fetus as 
Campylobacter jejuni, C. sputorum, C. coli, and C. fetus respectively. The isolate o f C. 
fetus they identified and characterized was a neotype strain distinct from the isolate 
reclassified in the 1963 study (254). Several new strains of Campylobacter have since 
been discovered and currently there are a total o f 18 species and subspecies within the 
genus (40) (Table 1.1). Most, but not all o f the currently known species are capable of
2
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causing disease in humans or animals, dispite this, most o f the pathogenic mechanisms 
associated with the different species remain to be elucidated. The role o f cytotoxins 
and/or enterotoxins in the dianheal response has been the subject o f many intensive 
investigations (257,259). Although there remains much controversy over the role toxins 
play in the infectious process, several cytotoxins (86.150) and at least one enterotoxin (14) 
have been implicated in the pathogenesis o f disease.
1.2 Taxonomy of Campylobacteriaceae.
The first taxonomic studies conducted on the genus Campylobacter primarily 
addressed the physical characteristics of the bacteria (254). The early studies compared 
growth rates on different media and at different temperatures monitored by microscopic 
examination o f motility and flagellar staining. Biochemical tests included oxidase, indole, 
catalase, nitrate reductase, H2 S production, glucose metabolism, and gelatin hydrolysis
(254). To further classify the genus, tolerance tests were conducted using various 
concentrations o f compounds such as glycine and bile along with antibiotic sensitivity 
testing (254). The % GC was determined and the identified strains were typed 
serologically using two antisera specific for the heat stable antigens (254). This study 
provided valuable information regarding the identified strains o f Campylobacter and 
provided criteria for future identification and classification o f the organisms within the 
genus (Table 1.1).
hr 1974 the genus Campylobacter was grouped with Spirillum in the family of 
Spirillaceae in Bergey*s Manual o f Determinative Bacteriology (231). This type of 
classification, based on common morphological and physiological characteristics, remained 
intact until 1984, at which time Sergey's Manual discontinued the family name 
Spirillaceae and grouped Campylobacter, Spirillum and Aquaspirillum together in one 
group. This classification prevailed until 1987 when a more in-depth approach led to the
3













Table 1.1. Phenotypic properties of Campylobacter species" (40)




















C. jejuni subsp. 
jejuni
+ + ■ “ - ■ + + + “ + + S R
C. jejuni subsp. 
doylei
V _ ■ • " V + * ■ “ + - S S
C. coti + + - - - - - + - + - + + S R
C. fetus  subsp. 
fetus
+ + - - - - - - - - + + V S
C. fetus  subsp. 
venerealis
+ + _ “ - - ■ + ■ - • + R S
C. lari + + - - V - - - + + - + + R R
C. upsaliensis w + - - - - - + - + - V - S S
C. hyointestinalis + + - V - + - - + - + + R S
C. sputorum 
biovar sputorum
- + + ~ + - - + + - + + S s
C. sputorum 
biovar bubulus





+ + + " " + • - • + + + R s
C. helveticus - + + - - - - + - + V V ND S s
C. mucosalis - + + + - + - - - + - + + R s
C. concisus - + + + - + - - - + - + + R R
C. cun’us - + + + - + - + - *f - + ND S ND
C. rectus - + + + - + - + - W - + ND S ND
C. showae + + ND + - + - + - + - V ND R S
aT Sl, trip le  sugar iron; W, w eak reaction; S, susceptible;V , variable; ND , not determ ined, bcatalase; curease; Cnalidixic acid
reclassification o f Campylobacters in the same group as the other Gram-negative bacteria 
(191). At this time, a study was conducted comparing partial 16S rRNA sequence data 
from 6 different Campylobacter species, including a strain o f  C. pylori (191). This genetic 
analysis showed that Campylobacters belonged to a previously undescribed eubacterial 
group closely related to Thiovulum, a microaerophilic sulphur-accumulating aquatic 
bacterium (191). Further analysis showed Campylobacter was related to the phylum o f 
purple photosynthetic bacteria commonly known as Proteobacteria (170). Additionally, it 
was found that C. pylori was more closely related to the genus Wolinella than the other 
Campylobacter species investigated (216). Upon closer examination of known 
Campylobacter species, three distinct rRNA groups were found. Current nomenclature 
places the true Campylobacters such as C. fetus and C. jejuni in group I while groups II 
and HI have been reclassified as Helicobacter sp. and Arcobacter sp. respectively (Fig 1.1) 
(253).
1.3. Identification and characterization of C. jejuni
Campylobacter sp. are microaerophilic, curved or S-shaped rods approximately 
0.2 to 0.9 pm wide and 0.5 to 5 pm long. They are non spore-forming, gram negative 
rods which may form coccoids following prolonged exposure to air and are motile by 
unsheathed polar or bipolar flagella (172). C. jejuni are catalase positive, urease negative, 
hydrolyze hippurate, nalidixic add sensitive and resistant to cephalothin (172) (Table 1.1). 
In a clinical setting C. jejuni are readily distinguished from the closely related species, C. 
coli, by determination of hippurate hydrolysis activity. Originally, Campylobacter were 
differentiated solely on the basis o f  bacteriophage type but later this approach was 
expanded to include biotype (147). Today there are 10 methods which are routinely used 
for differentiating Campylobacter, (i) serotype (147, 160); (ii) biotype (227); (ii) 
phagetype (120); (iv) pulsed-field gel electrophoresis (PFGE) (227); (v) ribotype (227);
5
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• Campylobacter curvus 
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l ------------- CLO strains
- - -  Arcobacter cryaerophilus
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Spirillum  517  5
CLO strain CCUG 13942
rRNA superfamily I to V
rRNA cluster III
Figure 1.1. Current taxonomic arrangement o f the genus and related organisms based on 
rRNA superfamilies (252).
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(vi) restriction endonuclease patterns (69, 173.184); (vii) random amplified polymorphic 
genomic DNA (RAPD) (67); (iix) plasmid profile (33); (ix) whole cell protein 
profile(227); and (x) polymerase chain reaction (PCR) specific for C. jejuni DNA (55). 
With these typing methods firmly established, it is possible to obtain valuable 
epidemiological information regarding probable sources o f C. jejuni infections and cross 
contamination. Currently there are two well defined serotyping methods for 
Campylobacter sp. One o f the serotyping schemes currently used for Campylobacter sp. 
is a passive hemagglutination assay based on heat-stable antigens which is commonly 
referred to as the Penner serotyping scheme (160). This method involves typing of the O 
antigen by allowing it to first sensitize erythrocytes followed by a slide agglutination assay 
with strain-specific antisera (160). Another serotyping scheme is based on the heat-labile 
factors and commonly referred to as the Lior serotype (147). It also utilizes slide 
agglutination assay technique using live bacteria and whole cell antisera absorbed with 
homologous heated and heterologous unheated cross-reactive antigens (147). Of the C. 
jejuni strains examined, there are 47 Penner serotypes and 55 Lior serotypes of human 
origin, 11 from non-human sources and 8 that are unknown (147).
Since a large number o f strains belong to common serotypes, it is often necessary 
to further differentiate each serotype and a biotyping scheme was proposed in 1980 by 
Skirrow and Benjamin to further sub-divide the more common serotypes (227). The 
investigators evaluated hippurate hydrolysis, production of HfeS on media containing 
ferrous, bisulfite and pyruvate (FBP) components and resistance to naladixic acid in order 
to subdivide C. jejuni into two biotypes (227). In 1984, Lior proposed a new biotyping
7
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
scheme using hippurate hydrolysis, production o f H2 S on FBP medium and DNA 
hydrolysis which further divided C. jejuni into four biotypes, providing further information 
for epidemiologic purposes (227). C. jejuni can also be further sub-classified based on 
phage type (120). By using 22 different typing phages, 52 different phage types have been 
identified for C. jejuni (120).
Pulsed-field gel electrophoresis (PFGE) has been used to distinguish very closely 
related strains o f C. jejuni. The information collected from PFGE can be used to 
determine if one or more strains o f C. jejuni is responsible for an outbreak of 
campylobacteriosis. This molecular technique is accomplished by comparing the 
chromosomal DNA banding patterns following digestion with specific restriction 
endonucleases which have a low frequency of cleavage sites. Different strains produce 
unique banding patterns due to variation in the sizes of fragments resulting from the loss 
or gain of restriction sites. PFGE can also be used to determine the average genomic size 
of C. jejuni and C. coli chromosomal DNA when fragments are compared to known 
molecular weight standards.
Recently, two molecular typing schemes have been developed for C. jejuni (69, 
173). The first is a comprehensive ribotyping typing scheme based on the heat-stable 
serotypes. This method uses a 16S rRNA polymerase chain reaction (PCR) generated 
amplicon in Southern blot analysis with genomic DNA previously digested with either Pstl 
or HaeTR (69, 185). This particular technique has identified 77 unique types o f C. jejuni 
based on banding patterns and shows there are three copies of the 16S rRNA gene (69).
A second method uses restriction fragment length polymorphism (RFLP) analysis of a 1.7-
8
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kb amplicon generated from the flaA  gene o f C. jejuni following digestion with Dde I 
(173). Although only a limited number o f  strains were used, the results showed that this 
method can discriminate between strains and determine copy numbers o f the flaA  genes 
(69, 173). RAPD has also been used for molecular typing (67). This typing method 
utilizes random, single 10-mer primers in the PCR reaction followed by separation of 
amplicons using agarose gel electrophoresis. Groupings of strains based on the flaA 
amplicons were found to be similar to the groups obtained using the ribotyping scheme 
(67).
Plasmid profiles o f various strains o f C. jejuni from human and non-human sources 
have been analyzed with respect to size, number and frequency o f extrachromosomal 
DNA (33). Plasmids were found in 22% o f human isolates and ranged in size from 3.2- to 
60-Mda (33) while 12.7% o f non-human isolates contained plasmids ranging from 1.3- to 
82-Mda (33). Plasmid profiles could be used for epidemiological purposes along with 
antibiotic resistance since tetracycline resistance is commonly carried on a 3 3- to 41-Mda 
plasmid (33, 249).
Protein banding patterns observed following non-denaturing polyacrylamide gel 
electrophoresis (PAGE) have also been found useful in distinguishing species of 
Campylobacters (114, 227). By analyzing the soluble proteins o f atypical strains following 
PAGE and Coomassie blue staining, it was possible to correctly identify these strains to 
the species and subspecies levels (227).
Several techniques have been developed to isolate C. jejuni directly from the 
environment and patient specimens. It was shown that a combination of a blood-free
9
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medium supplemented with cefoperozone and blood agar overlaid with a 0.65 pm filter 
was useful for isolation o f C. jejuni from clinical specimens (5). Filtering techniques in 
conjunction with PCR have also proved suitable for detection of C. jejuni from water 
supplies used on broiler farms (186) and from estuarine surface waters (96). Both 
methods use PCR to target a conserved region o f the flaA  gene followed by hybridization 
with a non-radioactive probe specific for the amplified region. C. jejuni has also been 
identified directly in stool by using PCR specific for the flaA  gene. By performing DNA 
purification using an extractor column directly on stool specimens, it was possible to 
identify and type C. jejuni in one step without needing to first culture the organism (255).
Several additional techniques based on hybridization with a species-specific DNA 
probe have been developed and these allow for identification o f C. jejuni in as little as 48 h 
(32,137,237). However, DNA probes are not the only means of identifying the organism 
using molecular techniques. The use o f monoclonal antibodies attached to magnetic 
beads, followed by PCR specific for the 16S rRNA of C. jejuni, has been shown to be 
effective in detecting the organism in milk and poultry samples (55). The use of 
monoclonal antibodies specific for membrane proteins was also able to identify C. jejuni in 
stools (38). While species-specific antibodies can be used to differentiate between 
thermophilic Campylobacters as well (84), targeting the gene for specific membrane- 
associated proteins such as map A has proven an effective method to speciate C. jejuni 
(237).
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1.4 Epidemiology and Disease.
1.4.1. Incidence of Disease.
Campylobacter enteritis is mainly associated with two closely related species in 
rRNA group I: C. jejuni and C. coli (171, 172,230). Although most laboratories do not 
distinguish between the two, an estimated 90% of Campylobacters isolated are C. jejuni 
(242). The exact number o f Campylobacter cases each year is difficult to determine since 
most go undiagnosed and many are not reported accurately. Voluntary laboratory 
reporting of Campylobacter cases in the United States has shown an incidence o f infection 
of 6 to 7/100,000, while active surveillance reveals an incidence o f infection to be 30- 
60/100,000 (230, 242, 243). When surveys were conducted in a general practice in 
England, an incidence o f  infection o f 1/100 was found (230) and similar studies conducted 
in the U.S. following a waterborne outbreak revealed a similar incidence o f infection 
(10/1000) (172, 230). Extrapolating these incidence rates o f Campylobacter infections to 
the total population o f the United States, an estimate of 2.5 million cases o f 
campylobacteriosis must occur annually (172,230) although most are not reported.
When compared to the incidence of other enteric pathogens such as salmonellae 
and shigellae, Campylobacter sp. are isolated twice as often as Salmonella sp. and four 
times as frequently as Shigella sp. (242). hi New Hampshire, campylobacteriosis has 
consistently been the fourth most common notifiable disease ahead of salmonellosis and 
behind giardiasis (242). Although not usually life threatening, each case of 
Campylobacter has been estimated to cost approximately 500 dollars (US) in health care 
and lost productivity, making Campylobacter enteritis a multi-million dollar disease (230).
The incidence o f campylobacteriosis in developing countries has been estimated to 
be several orders o f magnitude higher than that in developed countries (243). For 
example, in the region previously known as Yugoslavia, the incidence o f  infection in adults 
is equivalent to that in the United States, but in children 1-4 years of age there are an 
estimated 2500 cases for every 100,000 children (243). The incidence is even higher in
11
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Mexico and Thailand where there are approximately 0.4 episodes per child per year with 
an annual rate o f 40,000 cases/100,000 population (193,243). Recurrent infections are 
also much more frequent in developing countries, hi Thailand for example, a twelve-week 
study showed that 10% o f children tested under 5 years of age had weekly Campylobacter 
infections caused by different serotypes (243) and in Mexico, multiple serotypes of 
Campylobacter could be isolated from children during any given infection (243).
When excretion rates were examined in the Mexican and Thailand studies, it was 
found that isolation from healthy individuals was not due to carriage but was attributed to 
reinfection (243). Campylobacter sp. have been clearly linked to travelers' diarrhea when 
travel has included developing countries and in these cases the severity o f disease was 
found to be greater than that typically seen in the country o f travel (243). In industrialized 
countries the average duration of symptoms is between 1-7 days but an infected individual 
can shed the organism for up to 3 weeks following ingestion. The duration of shedding of 
organisms is much lower in developing countries with an average length o f  time of 14 days 
for adults and only 8 days for children aged 1 to 5 years. Shorter durations o f shedding 
could be attributed to actively acquired natural immunity rendering the children partially 
resistant (243).
Symptoms associated with campylobacteriosis include abdominal pain, fever, 
cramping, vomiting and diarrhea with or without blood and fecal leukocytes (172, 230, 
243). The symptoms tend to be less severe in developing than in developed countries 
while the frequency o f  mixed bacterial infection is much lower in developed than 
developing countries. Whereas most cases of campylobacteriosis are self-limiting, some 
instances require treatment with macrolids or fluoroquinolones to resolve the infection and 
eliminate  symptoms (172). Antibiotic resistance to erythromycin (245), fluoroquinolones 
(227,260), kanamycin (248) and tetracycline (249) are being seen more frequently and 
these emerging pathogens may pose a serious problem in the future with respect to 
effective treatment and prevention o f Campylobacter infections.
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1.4.2. Distribution o f Campylobacter.
Seasonal distribution o f campylobacteriosis is much different in developed than in 
developing countries. In developed northern countries, C. jejuni infections are lowest 
during the first and last four months o f the year with a surge in the summer months 
beginning in May (229, 230, 242, 243). The highest number o f cases are observed in July 
and August, possibly due to poor handling techniques o f infected food products (229, 
242). There is also an increase during the Thanksgiving and the Christmas holiday seasons 
due to increased consumption o f turkey and poultry as traditional foods (Fig 1.2). In 
developing countries, seasonal and holiday variation is much less o f an issue (243).
There is a bimodal distribution of disease among age groups in developed 
countries with the highest incidences occurring in children less than five years o f age and 
in young adults between 20 and 40 years of age (172, 242) (Fig 1.3). Additionally, men 
have a higher infection rate than women in all age ranges, but the bimodal distribution is 
maintained (242).
C. jejuni survive as commensals in the gastrointestinal tract o f a wide range of 
animals which can then serve as reservoirs for human infection (177, 229, 230, 236, 242, 
243,). The most common cause of outbreaks o f C. jejuni is from consumption of 
contaminated water or milk The major waterborne outbreaks that have occurred have 
usually infected large numbers o f individuals and were readily traced back to the source of 
contamination during investigation. This type o f infection usually occurs in areas where 
water chlorination is inadequate or where runoff from farms occurs following periods of 
heavy rain. Wild birds such as crows, gulls and pigeons frequently harbor C. jejuni and can 
therefore readily contribute to the contamination of untreated drinking
13

















Figure 1.2. Reported cases of Campylobacter isolates by month in the United 
States from 1982 to 1989 (243).
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Figure 1.3. Distribution of Campylobacter isolates in the United States by age and 
sex (243).
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water. Unpasteurized milk has also been linked to large outbreaks o f campylobacteriosis. 
In three documented cases attributed to contaminated milk, 148, 200 and 2500 individuals 
respectively, were infected with C. jejuni (63). A study was conducted to investigate the 
incidence o f C. jejuni carriage in diary herds and the results showed that 10 o f  the 12 
herds tested were positive for the organism and 10-72% of the cows tested were culture 
positive (102).
The most common source o f sporadic infection in developed countries is through 
the consumption o f undercooked chicken (236, 242,243). The infective dose of C. jejuni 
needed to cause disease has been disputed, but may be as low as Kp organisms and 
detailed surveys have shown that 60-80% of commercially available chickens harbor up to 
10^ Campylobacter per carcass (172, 236). Measures to remove Campylobacters from 
chickens include vaccination o f  the flocks, selection of chickens based on their resistance 
to colonization with the organism and irradiation of raw meat products. The common 
house fly has also been shown to carry C. jejuni and is suspected of transmitting the 
organism to previously uncolonized chickens (229, 236).
Colonization studies using mice show they can excrete viable organisms for 
months following exposure making them a potential reservoir for disease, especially on 
broiler farms (20). Beef and pork products may also serve as reservoir for disease, most 
likely becoming contaminated during processing. Campylobacter have also occasionally 
been isolated from fresh vegetables at farmers markets with greater than 80% of the 
isolates being C. jejuni (190).
1.5 Models of Campylobacter disease.
Many animal species have been examined in search of symptoms typical o f those 
observed in human campylobacteriosis and to serve as models for disease. It is not 
uncommon for a particular animal to become colonized with the organism without 
developing symptoms as evidenced by the large number of domestic and wild animals that
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are naturally colonized with these organisms This is an important observation since 
domestic cats and dogs can be chronic Campylobacter carriers and serve as potential 
reservoirs o f infection and disease since they are known to be asymptomatic carriers of the 
organism (236). However, in dogs less than 6 months o f  age, symptoms such as watery 
and bloody mucoid diarrhea can occur (72). Colonization has also been documented in 
hamsters and non-human primates living in captivity (72). This type of cross 
contamination is especially common in group environments and can lead to colonization 
with multiple serotypes o f C. jejuni (72) in animal colonies. Experiments using 
gnotobiotic and germ free puppies have been successful in establishing symptoms, but the 
high cost needed to maintain adequate facilities have made experimentation with these two 
models impractical.
In order to effectively study C. jejuni infections, it is desirable to have a model 
which produces those symptoms commonly seen in humans The criteria which must be 
met for selection o f a suitable model include: (i) it reproduces the pathology of the 
disease being studied; (ii) the animals are readily available commercially in sufficient 
numbers; (iii) it can be easily transported and exported; (iv) it is easy to maintain and 
handle in laboratories; (v) it is well characterized biologically; (vi) its disease status is 
established; and (vii) it is has a sufficient life span for the study in question (72).
Rabbits serve as suitable models for enteric pathogens such as Vibrio cholerae and 
enterotoxigenic Escherichia coli. Researchers have adopted the removable intestinal tie 
adult rabbit diarrhea (RTTARD) model to study C. jejuni infection but have had only 
limited success (34, 35, 63, 258). The RTTARD model permits enhanced colonization of 
the mucosa by inhibition o f normal peristaltic clearance (13, 258). Colonization by C. 
jejuni was thought to be facilitated by motility and the RITARD model has allowed for the 
in vivo comparison o f disease potential o f  motile and nonmotile strains of C. jejuni.
Results indicated that when both flagellate and non flagellate strains were inoculated in the 
RTTARD model, only flagellated Campylobacters were isolated from fecal samples
17
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signifying that any colonization 'with nonflagellated organisms which occurred was cleared 
more readily (258). The RITARD model has also provided information regarding the 
interaction o f the organism with the intestinal epithelial cells and has enabled evaluation of 
the organism for exotoxin production.
Mice have been used extensively as an infection model since they typically do not 
contain Campylobacter sp. as part o f their normal flora and because o f  the ease and the 
low cost associated with their use and maintenance (72). They have been used primarily 
for colonization studies because they do not generally exhibit the clinical symptoms 
associated with C. jejuni enteritis. Experiments have been performed to enhance the 
virulence o f C. jejuni by intraperitoneal passage in weanling pups using mucin or iron 
dextran. Following intragastric intubation o f passaged organisms into neonatal mice, the 
mice developed self-limiting campylobacteriosis. The LD5 0  o f the virulence-enhanced
strain was found to be 6-fold lower than before passage, thereby showing it to be an 
effective method for this purpose (116).
A mouse model was developed to evaluate colonization of mucus as a pathogenic 
mechanism for C. jejuni (144). The organism was able to colonize the outer surfaces of 
the mucus as well as deep within the intestinal crypts in gnotobiotic and germ free mice 
without evidence o f adherence to epithelial cells (144). The organism is highly motile in 
the mucus, and this is facilitated by its spiral shape which may help it colonize deep within 
the crypts thus protecting it from the peristaltic clearance action of the intestine. Rat ileal 
loops have also been evaluated, and by this method the production o f a cholera-like 
enterotoxin by C. jejuni was documented (220).
A chick embryo model has been used to assess virulence and invasiveness o f C. 
jejuni (67, 68, 126, 150). Results show that the strain o f C. jejuni and the host lineage of 
the chickens used can dramatically alter the outcome of the experiment, providing insight 
that virulence may be very strain-specific (126). Infant chicks, between 36- to 72 h old, 
have also been shown to exhibit campylobacteriosis similar to that in humans following
IS
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ingestion o f the organism (223). Invasiveness has also been studied using primary swine 
intestinal cells and results suggest invasion is an in vivo virulence characteristic o f the 
organism (13).
The use o f the Macaca nemestrina monkey as a model for disease has been 
reported (217.219) but due to the high cost associated with such a model, it has proved 
difficult to evaluate. Campylobacter sp. are commonly isolated from symptomatic 
monkeys in captivity showing that they can be colonized and infected in a fashion similar 
to humans. These animals  ^ like human also acquire protective immunity  following 
subsequent exposure to the organism (217, 218, 258).
The most widely accepted model for campylobacteriosis is the domestic ferret 
model (17, 18, 19, 73, 74). Ferrets are readily available and relatively easy to maintain, 
but more importantly, they have a gastrointestinal tract anatomically similar to humans 
(74). Ferrets have provided a model in which the immune response to C. jejuni can also 
be evaluated (17). Results show that passively acquired maternal antibodies to C. jejuni 
have a protective role while there is no evidence for the need for a cell mediated immune 
response for recovery (17).
1.6 Physiology of C. jejuni.
C. jejuni requires a microaerobic environment for growth and this can be quite 
problematic when large numbers of organisms or their products are required. A  biphasic 
system has been developed which allows for the microaerobic environment to be 
maintained and also supports optimal growth with a mean generation time o f  90 min 
(215). However, the organism can adapt to an aerobic metabolism after being left in air 
for a prolonged time. The adaptation was found to be maintained indefinitely following 
subsequent passages in air (110).
Typically, C. jejuni is a slender, gram negative rod in a microaerobic environment, 
but under adverse conditions such as nutrient limitation, aeration of the media or the
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presence of free radicals, it usually assumes a coccoidal morphology (27, 110, 142). 
Although coccoidal forms are usually found to be viable, prolonged exposure to these 
adverse conditions may lead to a degenerative stage rather than a dormant state (27). 
Changes in temperature, such as 25° C to 4° C, can also induce coccoidal formation which 
has been attributed to changes in the relative amounts of the different membrane fatty 
acids of the organism (95). For instance, there was a significant increase in the amount of 
16:0 and 18:0 fatty acids and a decrease in 14:0, 16:1 and 19:0 fatty acids (95). 
Temperature and pH have also been shown to induce the production o f stress proteins by 
the organism, leading to changes in the whole bacterial cell protein profile (269). It has 
been suggested that these changes in protein profile could have an adverse effect on 
adherence o f the organism to epithelial cells in vitro (131). One of these stress proteins 
has been purified and identified as a GroEL-like protein and has been classified as part of 
the heat shock 60 (HSP60) family o f proteins (241).
The chemotactic capabilities o f  C. jejuni have been studied along with the effects 
o f different substrates have on chemotaxis (100, 240). The only carbohydrate which was 
capable of inducing chemotaxis is L-fucose. However, bile, mucin and several salts of 
organic acids have also been shown to induce chemotaxis o f C. jejuni (100). The 
chemoattractant capabilities o f I^fucose, which is found in mucin and bile, may be of 
importance in the colonization o f the intestinal tract. Studies comparing the colonization 
rate o f the mouse intestinal tract have been performed using non-chemotactic mutant 
strains and chemotactic strains (240). Results from these studies show that chemotactic 
movement is important in that the non-chemotactic strains were cleared by the mice within 
48 h  while chemotactic strains readily colonized the mice for much longer periods of time. 
The growth of the organism in the presence o f bile salts has also been found to influence 
the production o f peritrichous-pilus like appendages which could be a virulence attribute 
o f the organism (57). Mutants deficient in these appendages were found to induce milder 
symptoms in the ferret animal model (57).
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1.7 Molecular characterization of C jejuni.
Characterization o f  C. jejuni can has been performed at a molecular level by 
evaluating strains for unique membrane proteins or for variations in lipopolysaccharide 
(LPS). The most common approach to evaluate the different components of the outer 
membrane o f C. jejuni is by glycine or sodium lauryl sarcosinate extraction followed by 
SDS-PAGE electrophoresis (119). Western blot analysis of surface exposed proteins 
using polyclonal antisera raised against whole C. jejuni revealed several proteins of 
various sizes in addition to low molecular weight LPS. Many o f the physical properties o f 
the proteins have been characterized (Table 1.2) and some o f the genes responsible for 
their production have been cloned and sequenced.
The most immuno-dominant protein associated with C. jejuni is flagellin (92).
Upon closer examination o f the different serotypes of C. jejuni. it was found that some 
strains produce two distinct flagellin subunits, FLAA and FLAB, each of molecular masses 
of 61.5 and 59.5 kDa respectively and both with an isoelectric point o f approximately 4.5 
(92, 148). The pathogenic implications o f the two subunits have not yet been elucidated 
even though the antigen has been found in several different species but can differ in 
molecular weight (161). Closely associated with the flagellin protein is a 92 kDa flagellar 
hook protein which is part o f  the locomotion apparatus and is thought to join the flagellar 
filament with the basal body ( 107, 206). The hook protein from C. jejuni has yet to be 
sequenced, but analysis o f  the N-terminal o f the protein, shows it to be identical to that of 
C. coli, while it possess very little homology with the hook proteins from Salmonella sp. 
and Caulobacter sp. (206).
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flagellin A(FlaA) 61.5 flagella protein A (92)
flagellin B (FlaB) 59.5 flagella protein B (92)
Hook protein 92 Join the flagellar filament to the intramembrane located 
basal body
(107)
MOMP-porin protein 43 forms small channel with single channel conductance (26)
Omp30 30 unknown (60)
MAPA 24 corresponding gene is used for speciation of C. jejuni by 
PCR; function of protein is unknown
(237)
PEB-1 28 unknown (31)
PEB-2 29 unknown (31)
PEB-3 30 potential homology with class I pili from Neisseria 
meningitidis and if. coli heat-labile enterotoxin B subunit
(31)
PEB-4 31 partial homology with serine protease inhibitor 
superfamily
(31)
Ompl8 18 similarity to peptidoglycan-associated lipoproteins (135)
catalase 58 catalyses the dismutadon of H2O2  to H20  and Q> (83)
superoxide dismutase 
(SodA)
24.8 catalyses the dismutation of superoxide radicals (208)
Fur 17.9 Fur-like iron-responsive genetic regulatory protein (43)
gamma-glutamyl phosphate 
reductase (ProA)
46 involved in the conversion of L-glutamate to proline (149)
histone-like (Hup) 11 binds to DNA and induces the condensation of DNA into 
bead-like structures
(134)





40 enzyme involved in leucine biosynthesis (141)
RecA 37 recognizes single stranded DNA and anneals it to a 




105 enzyme involved in aminoacylation of isoleucyl-tRNA (98)
kanamycin
phosphotransferase
29 confer kanamycin resistance (248)
trigger fector 56 thought to be involved in cell division (85)





56 cleaves argininosuccinic acid into arginine and fumarate (89)
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The major outer membrane protein (MOMP) present in the cell wall o f C. jejuni has been 
identified as a porin, with a calculated molecular weight of 43-kOa and has been identified 
in approximately 60% o f pathogenic strains o f  C. jejuni (26, 103, 118). When the 
MOMP was purified and reconstituted in a lipid bilayer, it formed a channel with a 
conductance of 8.82 nS in 1M KC1 (103). Conformational analysis o f the porin protein 
showed it was a trimer formed by three folded monomers with a high degree of (3-sheet 
secondary structure. It was also found to be immunologically similar to the OmpC protein 
in E. coli (118) and has been classified as part o f the trimeric porin family (103). 
Membrane proteins have also be used to identify C. jejuni from other Campylobacter sp. 
as well as to distinguish between thermophilic and non-thermophilic Campylobacters (60). 
Thermophilic Campylobacters contain a unique, immunologically similar 3 1-kDa protein 
expressed on the surface o f the organism and this protein is absent in non-thermophiles 
(60). Another surface protein has been identified and termed membrane associated protein 
A (MAPA), which can help distinguish between C. jejuni and other Campylobacter sp.
The unique C. jejuni species-specific 24-kDa protein was first identified by screening a 
genomic library with antisera raised against C. jejuni only. This finding led to a PCR- 
based technique which is specific for the mapA gene, which encodes for the specie specific 
membrane protein and provides a means o f identifying the organism (2 3 7 ).
Glycine extractions have lead to the purification and characterization of several 
other outer membrane proteins (OMP) (30, 31, 38, 65, 119, 154). Four such proteins are 
considered to be major common antigens present on the surface of C. jejuni (31). 
Originally they were referred to as cell binding fractions (CBF) (65) but have since been
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renamed FEB 1-4 (31). These proteins are basic in nature and have calculated molecular 
masses o f 28-kDa (PEB1), 29-kDa (PEB2), 30-kDa (PEB3) and 3 1-kDa (PEB4) (31). 
Only PEB1 and PEB3 are capable o f eliciting an immune response in humans, making 
them potential targets for vaccine development. Recently, the PEB4 protein was cloned 
and sequenced and shown to be highly conserved genetically among other isolates o f C. 
jejuni (31). An 13-kDa OMP has also been cloned and sequenced and shown to have 
genetic homology with a peptidoglycan-assodated outer membrane lipoprotein P6 o f 
Haemophilus influenzae (30). An intracellular iron-binding protein has also been purified 
and characterized and found to be similar to the protein ferritin from Helicobacter pylori 
and Bacteroides fragilis which are more closely related to eukaryotic ferritin than 
bacterioferritin (256).
A major component of the outer membrane o f C. jejuni is the LPS and some of the 
carbohydrate moieties present in the LPS have been characterized using nuclear magnetic 
resonance (NMR). C. jejuni contains low oligosaccaharide (LOS) which can only be 
detected with a modified silver staining protocol in addition to the high molecular weight 
LPS containing O-side chains which can only be visualized on immunoblots using strain- 
specific antisera (9, 158). Two of the Penner serotypes, 0:4 and 0:19, have been found 
to contain core oligosacchrides with terminal structures similar to GMi and GDia 
gangliosides present on human nerve tissues (8, 277). They also contain sialic add 
residues which are typically found on glycosylated eukaryotic proteins (158). Sialic acid 
residues are considered to be weak immunogens but may offer some resistance to 
bacteriddal antibodies normally present in serum (158). Thin layer chromatography
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studies have shown that there are also epitopes present on the LPS from isolated strains o f 
C. jejuni similar to GQib and GD3 ganghosides (221, 278).
Currently, little is known about the genetic structure and function o f most of the 
genes present on the chromosome of C. jejuni since relatively few have been cloned and 
sequenced successfully (244). However, the average size of the genome as determined by 
PFGE, is 1.72 Mb (44, 122,246). Mapping o f the genome using hybridization techniques 
with known sequences from other bacteria allowed for the elucidation of the genetic 
organization o f several "housekeeping" genes (246). "Housekeeping" genes are those 
which are highly conserved between different species of bacteria and which can be used to 
map the genome from unknown bacteria even if  very little is known about the genetic 
organization o f the bacterium in question (244).
Genetic studies conducted on C. jejuni have shown it to be susceptible to the three 
common genetic transfer mechanisms: transformation, conjugation and transduction (244, 
248, 261, 263). The uptake of naked D N A  (transformation) has been shown to occur in 
C. jejuni and, although it will take up foreign DNA, it preferentially takes up its own (261, 
263). This can be demonstrated by incubating C. jejuni with DNA fragments containing 
the antibiotic determinant tetM, which confers resistance to tetracycline, and could explain 
the increase in antibiotic resistance among some clinical isolates (261). Conjugal transfer 
o f plasmids between strains of C. jejuni carrying antibiotic resistant determinants has also 
been documented (244, 248). Bacteriophage transduction has been used to type C. jejuni, 
but antibiotic resistance determinants (244) and potent cytotoxins (182) are known to be 
carried on phage in other genera, thereby causing a change in the characteristics of the
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strain infected with the phage. C. jejuni has also been shown to exhibit recombination and 
horizontal gene transfer as evidenced by variation o f the flagellar gene locus (264). This 
mechanism may allow adaptation o f the organism or provide a means for it to escape the 
immunological response of the host.
A compilation o f the C. jejuni genes which have been cloned and sequenced are 
summarized in Table 1.3. Many researchers have encountered difficulties with cloning and 
gene expression in C. jejuni. The most common problems are failure o f the genes to be 
expressed. Dispite the fact that the gene o f  interest has been successfully cloned, 
problems o f gene instability, cloning only a portion o f the gene of interest and post 
translational modification problems result in expression failures (244). Expression 
problems could also be explained by the presence o f unusual promoters not recognized by 
recipient cells or failure to process gene products as well as differences in methylation 
leading to instability. The construction o f new cloning vectors has alleviated some of the 
problems and hopefully their use will lead to  a better understanding o f C. jejuni genetics 
(244, 271) and pathogenicity.
1.8 Immune response to C jejuni infection.
With a suitable model, it would be possible to study the pathogenic mechanisms of 
C. jejuni and the immune response elicited by the host. Rabbits have not only been used 
as a model for colonization but have also been used to evaluate the immune response 
against selected components of the organism. For instance, both the serological typing 
schemes, Lior et al. (147) and Penner et al. (160), are conducted using rabbit polyclonal 
antisera against the heat-labile and somatic O antigens, respectively. Rabbits have also
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Table 13 . Summary o f the genes which have been cloned and sequenced from C. jejuni.
Gene cloned MW
(kb)
Cloning strategy location seq.
pub.
Ref.
DNA gyrase (gyrA) 2.6 Reverse genetics3 Chrom. Yes (260)
trigger factor {tig) 1.5 XZapII and antibody Chrom. Yes (84)
ferric uptake regulatory gene (fur) 0.86 pGem and hybridization Chrom. Yes (43)
Ompl8 (omplS) 0.5 pBluescript II SK+ and antibody Chrom. Yes (135)
catalase (katA) 1.5 pTZ19R vector Chrom. Yes (83)
isoleucyl-tRNA synthetase (ileS) 2.7 pBluescript and hybridization Chrom. Yes (98)
kanamycin resistance genes (aphA-7) 0.75 pBR322 vector Plasmid Yes (248)
tetracycline resistance gene (let) 1.8 pBR322 and hybridization Plasmid Yes (249)
superoxide dismutase (sodA) 0.66 pTZ19R and hybridization Chrom. Yes (208)
gamma-glutamyl phosphate reductase 
(praA)
0.3 pBR322 and hybridization Chrom. Yes (149)
histone-like DNA binding protein 
(hup)
0.4 XZapK and antibody Chrom. Yes (134)
ribosomal RNA - pBR322 and hybridization Chrom. No (123)
lysyl-tRNA synthetase (lysS) 1.5 pBR322 and hybridization Chrom. Yes (41)
leucine biosynthesis genes (leu) - pHC79 cosmid Chrom. No (141)
flagellin (JlaAJlaB) 1.7 XGT11 and antibody Chrom. Yes (180)
cytolethal distending toxin gene 
(cdtABO
2.3 PCR and hybridization Chrom. Yes (202)
serine hydroxymethyl transferase 
(glyA)
1.2 Reverse genetics3 Chrom. Yes (40)
acetylomithinase (argE) - Reverse genetics3 Chrom. Yes (244)
major cell-binding factor (peb4A) 0.821 XGT11 and antibody Chrom. Yes (31)
major cell-binding factor receptor 0.728 XGT11 and antibody Chrom. Yes (31)
major cell-binding factor (pebl) 0.779 A.GT 11 and antibody Chrom. Yes (194)
membrane-associated protein A 
(mapA)
0.6 pBluescriptllSK and antibody Chrom. Yes (238)
fructose 1,6-bisphosphate aldolase 
(fdaC)
0.577 DNA sequencing Chrom Yes (31)
argininosuccinate lyase (argH) 1.4 Reverse genetics3 Chrom. Yes (88)
aspartate-semialdehyde dehydrogenase 
(asd)
1.13 - - Yes Genb
creB 0.2 - - Yes Genb
5-enolpyruvinylshikimte-3-phosphate 
synthetase (aroA)
1.28 - - Yes Genb
lytB 0.83 - - Yes Genb
GTP cyclohydrolase I (folE) 0.637 DNA sequencing Chrom. Yes (84)
ATP dependent casein protease (clpP) 
(partial)
0.147 DNA sequencing Chrom. Yes (84)
transcription regulation gene (JhA) 0.845 AZapII - Yes Genb
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Gene cloned MW
(kb)





1.1 pBR322 and activity Chrom. Yes (89)
high temperature required gene/serine 
protease QttrA)
1.1 - - Yes Genb
regX 0.256 - - Yes Genb
tRNA-Leu 0.076 ABG51 and hybridization Chrom. Yes (124)
tRNA-Iso 0.076 ASG51 and hybridization Chrom. Yes (124)
tRNA-Ala 0.075 ADG51 and hybridization Chrom. Yes (124)
5S rRNA 0.719 ABG51 and hybridization Chrom. Yes (124)
16S rRNA 1.5 ABG51 and hybridization Chrom. Yes (124)
23S rRNA 0.8 ABG51 and hybridization Chrom. Yes (124)
recA 1.03 pUC18 and hybridization Chrom. Yes (87)
arylsulfatase (atsA) 1.8 pYG665 vector Chrom. Yes (272)
phenylalanyl-tRNA synthetase beta 
chain (phHeS)
0.3 - - Yes Genb
flagellar biosynthesis gene (IcrD/flbF) 2.2 pSM31 and hybridization Chrom. yes (157)
26 kDa protein gene 0.7 - - Yes Genb
61 kDa protein gene 1.7 - - Yes Genb
histidine periplasmic binding protein
(hisJ)
0.797 - - Yes Genb
a Reverse genetics refers to complementation of an E. coli mutant by cloned gene(s) from 
Campylobacter species (e.g. complementation o f proA and proB mutations) (244).
Genb, sequence available only through Genbank
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been used to study the antigenic nature and variations in flagella of the organism (72, 92). 
Western blot analysis using rabbit whole cell antisera raised against flagellated (F+), motile 
(M+) strains showed strong reaction with the 63-kDa flagella protein which was absent 
from aflagellated (F-), non motile strains (M-). It was found that the amino-terminus, the 
carboxy-terminus and the center o f both FLAA and FLAB proteins are highly 
immunogenic as determined by specificity studies using monoclonal antibodies (57.92. 
175). These regions of the flagella could be used as targets for serodiagnostic tests and 
vaccine development especially as they have been shown to be involved in adherence of 
the organism to the host (24, 268). Rabbit polyclonal anti-flagella antibody has been used 
to test efficacy as a potential vaccine in rabbits. Results showed that by pretreating the 
organism with the anti-flagella, colonization was drastically reduced when compared to 
colonization with untreated bacteria (57).
C. jejuni was found to stimulate  both the mucosal and the systemic immune 
systems o f infected rabbits and it was clear that humoral and mucosal immunity both play 
a role in inhibiting the colonization and bacteremia that often follows subsequent exposure 
to the organism (184). The mucus covering the villi in the intestine was shown to be 
readily colonized by C. jejuni, except when the rabbit had been previously colonized. This 
is because the secretory immunoglobulin A (slgA) present from previous infections and 
the glycoprotein component present in the mucus (called mucin) inhibit binding of the 
organism to underlying cells (155). The movement o f slgA-coated bacteria in the mucus 
is dramatically reduced and in conjuction with glycoproteins in the mucus, large 
aggregates are formed which are then removed by normal intestinal peristalsis (155).
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Mice have also been used to study the inflammatory response and intracellular 
survival o f C. jejuni (121,187). One research group showed that the organism was 
phagocytized in vivo by macrophages and killed within the first 24 h following 
intraperitoneal challenge of BALB/c mice (187). Contradictory results show that C. jejuni 
can survive within mononuclear phagocytes for an extended period o f time, which could 
be facilitated by the conversion o f the organism to a coccoidal form instead o f the 
traditional rod shape (121). Mice have also been used to evaluate the vaccination of 
mature females prior to mating. Results show that greater than 50% of the pups bom to 
previously vaccinated mothers were protected from colonization when allowed to receive 
their own mother's colostrum (1, 2). Protection was found to be mediated by high levels 
o f anti-C. jejuni IgG antibodies found in the mammary secretions, while IgA levels remain 
low (l, 3).
The role o f the macrophage and complement in C. jejuni infections have been 
studied by comparing the mortality rate o f mice depleted of both components (16). Mice 
depleted o f  macrophages following injection intraperitoneally with either silica dust, 
Liquoid, or dextran sulfate, had a mortality rate of 64% compared to 25% for undepleted 
control mice (16). Decomplementation o f the mice, induced by injecting cobra venom 
factor intraperitoneally, had little effect on mortality, suggesting that complement may not 
be important in alleviating infections (16).
The effects o f  recombinant interleukin (rIL) 2, 5 and 6 on colonization of mice 
with C. jejuni has also been investigated. Results show that rlL-5 and rEL-6 reduced the 
number o f organisms shed in the feces while rIL-2 had no effect on the colonization rate
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(15). Campylobacter-specific IgA was also increased in rIL-6 treated mice as opposed to 
those treated with rIL-5 and rIL-2. IL-2 treated mice were more resistant to 
recolonization following subsequent challenges (15).
The majority o f  humans with campylobacteriosis develop a full range o f  antibodies 
against antigens present on the organism as demonstrated by complement fixation, 
agglutination, enzyme linked immono-sorbant assay (ELISA) and Western blot analysis 
(178). Antibodies specific for C. jejuni can be detected at around 6 or 7 d after initial 
onset of symptoms and this is followed by a rapid increase in IgG, IgM and IgA levels. 
Levels o f IgM and IgA peak 7 to 10 d after symptoms are first recorded but decline 
rapidly while IgG levels peak at 3-4 w and remain at high levels for several months (178). 
Studies o f the intestinal mucosa o f infected humans have found there is an increased local 
immune response with high levels o f C. jejuni-specific slgA; however, data regarding the 
role o f the cell mediated immune response at the mucosal level are not available (178).
The presence o f anti-C. jejuni flagella IgA antibodies in human breast milk has been 
shown to provide passive protection against Campylobacter infections similar to that seen 
in mice (1, 2, 174). This process is most important in developing countries where 
Campylobacter infections are more prevalent. A number o f studies have assessed the 
human immune response to C. jejuni proteins and LPS. Proteins, present in the cell wall 
and ranging from 92-kDa to 14-kDa, were found to elicit an immune response. In these 
studies, the flagellar proteins are the most immuno-dominant (9, 159, 189).
The human immune response to the LPS of C. jejuni has gained much attention 
recently. Analysis o f human sera show that IgG, IgA and IgM molecules react with the
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LPS o f C. jejuni following exposure (25). Recent reports have indicated that individuals 
with campylobacteriosis induced by 0 :4  and 0:19 Penner serotypes o f C. jejuni may be 
predisposed to the type o f autoimmune response seen in Guillain-Barre syndrome (GBS) 
and Miller-Fisher syndrome (MFS) (165, 25, 214). Both conditions are neuromuscular 
disorders characterized by paralysis induced by demyelination o f the peripheral nerves 
(210). As stated earlier, approximately 1% o f the population contract campylobacteriosis 
in any given year and o f these 1-2/100,000 go on to develop GBS while o f those with 
GBS 15-40% were documented as having had a preceding infection with C. jejuni (139, 
276). Western blot analysis shows cross reactivity between sera from GBS and MFS 
patients and the LPS from C. jejuni. Closer examination of the carbohydrate moieties 
present in the LPS revealed an epitope similar to GMi ganglioside present on neural 
tissues (8, 139, 275). About 50% o f patients with anti- GMi antibodies have had a recent 
case o f campylobacteriosis caused by C. jejuni (101). The LPS has also been shown to 
induce antibodies against GM2, G D ia, GDib and GTib gangliosides (210, 278). Both 
features can lead to an autoimmune response against neural tissues leading to an acute 
neuromuscular paralysis while 5-10% of those inflicted with this condition die due to 
complications (6).
Miller Fisher syndrome is usually considered a milder form o f GBS and is typically 
characterized by external ophthalmoplegia, cerebral ataxia and lack o f tendon reflexes 
(278). Patients with MFS have been found to contain high levels of anti-GQ lb IgG 
antibodies (106, 278) and most individuals who develop MFS have also had a documented 
case of campylobacteriosis prior to onset of neurological symptoms (106). One of the
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strains o f C. jejuni isolated from a MFS patients was shown to cross react with anti-GQib 
antibodies present in their serum (278). A  recent report has linked the onset o f MFS with 
a case o f camplyobacteriosis caused by a strain of C. jejuni with LPS resembling 
ganglioside GD3 (221). These finding supports the hypothesis that molecular mimicry 
exists between C. jejuni and the neural tissues in the patients diagnosed with MFS (106, 
221,278).
1.9 Pathogenic mechanisms of C jejuni
It is highly likely that C. jejuni possesses several pathogenic strategies for disease 
induction. For instance, they adhere to host cells, become engulfed by the cells and 
undergo intracellular replication. In addition, C. jejuni produces a range of potent 
exotoxin(s). Some strains both infect cells and produce toxins. Studies have been 
conducted on the adhesion and invasion capabilities o f C. jejuni with a number of 
transformed cell lines (29, 130, 132, 136, 218). Results show that clinical isolates were 
more invasive than nonclinical isolates and that invasion can be reduced by pre-treating the 
organism with sodium meta-periodate which oxidizes the carbohydrate moieties present 
on the cell surface (132, 154). Adhesion and invasion of CaCo-2 cells by C. jejuni can 
also be drastically reduced following treatment of the host cells with D-glucose, D- 
mannose, and D-fiicose (218). These results suggest that a carbohydrate molecule present 
on the cell surface may be involved in adherence of some strains of the organism to host 
cells (154).
C. jejuni attaches to M cells in the intestine and has been seen in the underlying 
follicle by transmission electron microscopy (34,258). Adherence o f the organism to
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extracellular matrix com ponents such as collagen, fibronectin and laminin have been 
demonstrated and several o f  the bacterial surface components have been evaluated for 
their potential role in the adhesion process (140). The flagellin protein adhere to epithelial 
cells and to mucous present in the intestine. Binding experiments were conducted in the 
presence o f KCN which immobilized the flagella and resulted in an increased binding of 
the organism to  host cells (154). Other studies have found similar results with respect to 
increased adherence with flagellated, non-motile strains (177). Although flagellin 
functions as an adhesion molecule, it has also been implicated in increased internalization 
of the organism (82). This was demonstrated when non-motile, non-flagellated {flaA- 
flaB- MOT-) strains were internalized 6 to 7-fold lower than non-motile, flagellated 
(flaA+flaB+ MOT-) strains thereby suggesting a possible dual role o f flagellin in binding 
and uptake (82).
Several surface proteins, along with glycine extracted CBF (PEB) membrane 
proteins, are involved in adherence to HeLa and HEp-2 cells in vitro (65,119, 168). The 
CBF (PEB) membrane proteins range in size from 28- to 32-kDa, and are considered 
major common antigens on the cell surface. In competitive binding assays, CBF1 (PEB 1) 
was found to inhibit adherence o f the organism to a greater extent than CBF2 (PEB4), 
thus making it a potential target for vaccine development (119). Other proteins present on 
the surface o f  the organism, ranging in size from 36- to 42-kDa, isolated from an adherent 
strain of C. jejuni, also attach to host cells (38).
The invasion process was critically affected by temperature since invasion of 
actively metabolizing host cells was inhibited at 4 ° C (136, 218). Pretreatment of CaCo-2
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with micrafilflment inhibitors such as cytochalasm D and vincristine, had no effect on 
invasion o f  INT-407 cells, suggesting that microtubule-dependent endocytosis is cell-line 
specific (218) and may not be required for C. jejuni uptake. Invasion of the organism can 
also be facilitated by coinfection with other bacteria (29). Coinfecting with either S. 
typhimurium 0 1 E. coli, a previously non-invasive strain could be internalized by host 
cells. Intracellular survival o f  C. jejuni following the invasion process has been studied by 
quantifying superoxide dismutase production (199). This enzyme catalyzes the 
breakdown o f superoxide radicals to hydrogen peroxide and dioxygen which is essential 
for the intracellular survival o f  the organism and to prevent oxidative damage to the 
organism (199).
The expression of different proteins by C. jejuni following cocultivation with INT- 
407 cells, a human derived epithelial cell line, has also been studied (130). Protein gel 
electrophoresis demonstrates an induction in protein synthesis with production of 14 
additional proteins which are normally absent in organisms cultured in medium alone. 
These proteins appear to be essential for the microbial internalization process. Growth of 
the organism in the presence of protein synthesis inhibitors such as chloramphenicol 
followed by inoculation on to host cell monolayers prevents uptake of the organism by 
host cells. However, these antibiotics do not effect adherence of the organism (130).
There is much controversy regarding the diversity and pathogenic involvement of 
extracellular products produced by C. jejuni. Early studies looked at the production of 
extracellular factors by C. jejuni, both in cell lysates and in supemate. From these studies, 
it was found that the organism generated products that possessed leukocidal and
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hepatotoxic activity (127,129). While the hepatoxm produces lesions in the liver leading 
to hepatitis in mice (127), the leukotoxin was responsible for destruction of cell surfaces 
o f intoxicated leukocytes (129). It is interesting to note that an infection with the 
organism produced the same effects as the purified hepatoxic and leukocidal factors while 
in the chicken embryo model o f infection, the supernatant fluid from organisms grown in 
broth induced similar histopathological changes in the embryo tissue as did the organisms 
(150). Some strains o f C. jejuni produce alpha and beta hemolysins (162). Although 
hemolysin production was influenced by the pH of the media, iron and the species of red 
blood cells used had no effect on the hemolytic activity o f the organism (162, 200).
C. jejuni has been studied extensively for the ability to produce an enterotoxin (47, 
52, 53, 108, 115, 128, 239). Early studies used the receptor ganglioside GMi specific for 
the V cholerae and E. coli enterotoxin, along with antisera raised against the enterotoxins 
for detection and quantitation o f a C. jejuni enterotoxin. This cytotonic factor from C. 
jejuni could be neutralized by either antisera and was capable of inducing fluid 
accumulation in rabbit ligated ileal loops similar to E. coli and V. cholerae enterotoxins 
(128). Subsequent studies showed the presence of an enterotoxin capable of inducing 
accumulation o f cyclic adenosine monophosphate (cAMP) in cells exposed to the toxin in 
a fashion similar to E. coli and V. cholerae enterotoxins (62, 108). DNA hybridization 
studies using oligonucleotides specific for the GMi binding site on the toxB gene from V. 
cholerae and the heat labile toxin gene eltB ScomE. coli, demonstrated homologous 
regions on the C. jejuni chromosome but no gene could be cloned or sequenced (36). 
Recent studies have characterized and partially purified two proteins approximately 70-
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kDa (53, 133, 153) and 50-kDa (47) in size having immunological similarities to cholera 
toxin and which are capable o f recognizing GMi (239). Studies using the rat ileal loop 
and enterotoxigenic strains o f  C. jejuni displayed impaired Na+ and K+-ATPases, leading 
to changes in Na+ and CF transport and fluid accumulation in the lumen of the ileum (113). 
This can be demonstrated with the organism or organism-free filtrate, suggesting the 
production o f  an extracellular enterotoxin by the organism. However, the available 
information regarding the involvement o f an enterotoxin in the pathogenesis of 
Campylobacter diarrhea has been disputed and remains unresolved (196, 197, 133).
The production o f one or more cytotoxins has been demonstrated and identified by 
assaying the filtrate for cytotoxic activity by using a rapid dye reduction assay to screen 
many different strains and serotypes of C. jejuni or by antibody blocking assays (71, 108, 
151, 164, 163). The first reports showed it was heat-labile and sensitive to trypsin and 
could induce cytopathic effects in a number o f different cell lines (151, 273). Further 
studies showed the cytotoxin could not be neutralized by antisera raised against Shiga-like 
toxin I and II or by anti-Clostridium difficile antisera and it was greater than 14-kDa in 
size by gel filtration (85). Although the production o f a Shiga-like cytotoxin by C. jejuni 
has been demonstrated following neutralization studies using anti-SLT-1 B subunit 
monoclonal antibody, DNA hybridization studies using cloned SLT-1 genes were 
consistently negative (167). The RITARD assay and experiments using partially purified 
toxin implicated a protein greater than 30-kDa having the capabilities of inducing diarrhea 
in the rabbit model (188). A 68-kDa cytotoxic protein, which was virulent to chick 
embryos (150), has been isolated and its activity could be inhibited by pretreating host
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cells with neuraminidase and proteases, suggesting the receptor for this cytotoxin is 
glycoprotein in nature (151). Another cytotoxin is closely associated with the LPS (115) 
and following DEAE-cellulose column chromatography, two protein bands of 59- and 36- 
kDa were characterized but it is not known whether these proteins constitute toxin 
subunits (166).
A third type o f exotoxin, cytolethal distending toxin (CLDT) has been partially 
characterized and has recently been cloned and sequenced (109, 202). It is a slow acting, 
progressive toxin, the effects o f  which are best observed after 96 h in tissue culture. This 
toxin has been shown to cause an increase in cAMP levels and functions like an 
enterotoxin (109). Sequencing of the intact gene revealed three open reading frames 
designated cdtA, cdtB, and cdtC corresponding to proteins o f approximately 30-kDa, 29- 
kDa and 21-kDa respectively (202). An ELISA based system, using putative CHO and 
HeLa cell receptors for CLDT, has been developed for rapid identification of CLDT (14). 
The roles that the diverse reported exotoxins play in the pathogenesis of C. jejuni have not 
been elucidated.
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SECTION n
Isolation and characterization of a cytotoxic porin-lipopolysaccharide 
complex from Campylobacter jejuni
2.1 Abstract
Campylobacter jejuni is a major cause o f acute gastroenteritis worldwide and 
toxin production by organisms in the Campylobacter genus is controversial. A  clinical 
isolate o f C. jejuni was previously found to produce a toxin active in cell culture assays 
and this strain was used for subsequent identification and characterization of a cytotoxic 
porin-LPS complex. This cytotoxic complex was isolated following high performance 
liquid chromatography o f crude concentrated filtrate using a combination of size exclusion 
and DEAE-anion exchange chromatography. The complex had a specific activity o f 20.1 
TCDso/pg protein for HEp-2 cells, 7.49 TCD50/pg protein for HeLa cells and 1.87 
TCDso/pg protein for Chinese Ham ster Ovary cells. The isolated cytotoxic complex was 
analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis and contained a 
single protein with a calculated molecular mass o f 45 kDa in addition to a high molecular 
weight carbohydrate moiety identified after staining with silver and periodic acid Schiff 
respectively. The complex gave a positive Limulus amebocyte lysate test, suggesting that 
the co-purifying carbohydrate was lipopolysaccharide with specificity for
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lectins Galantkus nivalis agglutinin (GNA), Maackia amurensis agglutinin (MAA) and 
Datura stramonium agglutinin (DSA) but not for Sambucus nigra agglutinin (SNA) or 
Peanut agglutinin. The cytotoxic activity associated with the complex was heat labile at 
70°C, resistant to inactivation with trypsin and retained activity after treatment with 
sodium meta-periodate and the glycosidases neuraminidase and N-glycosidase F. 
Sequencing o f the N-terminus of the protein component o f the complex revealed a 97% 
homology with the major outer membrane porin protein from C. jejuni. The cytotoxic 
activity o f  the complex was neutralized by polyclonal, homologous antisera which reacted 
on Western blot with the 45-kDa protein. The cytotoxic activity was not neutralized by 
polyclonal antisera raised against a number o f previously recognized bacterial toxins 
including Escherichia coli verotoxin types 1 and 2, C. jejuni and E. coli cytolethal 
distending toxin, Vibrio cholerae enterotoxin and Clostridium difficile cytotoxin.
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2.2 Introduction
Campylobacter jejuni is a major cause of bacterial-induced gastroenteritis in both 
developed and developing countries. Active surveys conducted in the United States have 
estimated the incidence o f gastroenteritis associated with C. jejuni to be in the order of 1 
case per 100 o f the population and this corresponds to approximately 2.5 million cases per 
year (230). This estimated rate is twice that reported for salmonellosis and four times that 
for shigellosis (242). Although campylobacteriosis can persist for up to 7 days, most 
cases are self-limiting and only occasional instances require antibiotic and rehydration 
therapy for effective treatment.
M echanism s o f pathogenesis in C. jejuni infections remain controversial. The 
organism has been reported to be invasive and to express pathogenicity in a manner similar 
to other enteric pathogens such as Yersinia (203) and Shigella (273). In addition, toxic 
mechanisms have also been suggested, with a variety of toxins having been implicated and 
described (225, 259). One such toxin from C. jejuni is an enterotoxin with serological and 
ganglioside-recognition properties similar to that produced by Vibrio cholerae (1 1 5 , 239). 
C. jejuni produces another distinctive toxin, the cytolethal distending toxin (CLDT) which 
induces slow and progressive cytological changes in Chinese hamster ovary (CHO) cells 
and other cells including Vero, HEp-2 and HeLa (109, 202). The CLDT gene has been 
cloned and sequenced, revealing three open reading frames designated cdtA, cdtB and 
cdtC encoding for 30-, 28- and 19- kDa proteins respectively (202). Expression studies 
showed that all three genes must be present for the production o f active CLDT (202) and 
the role o f this toxin in pathogenesis has yet to be established.
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The production o f  other cytotoxins has also been described (85, 108, 115, 150, 
151,166) and some have been partially characterized (151, 166). Little is known 
regarding the structure and function o f these cytotoxins but, in general, they are reported 
to be heat-labile, sensitive to trypsin degradation, and greater than 14 kDa in size as 
determined by size exclusion column chromatography (85). Cytotoxic activity is also 
associated with the lipopolysaccharide (LPS)-rich fraction o f the organism (166) but 
currently the role LPS plays in the toxic response is unknow n . Despite numerous reports 
in this subject area, little is known about the role played by exotoxins in Campylobacter 
disease; indeed, it is probable that a combination of virulence factors act in concert to 
realize the full pathogenic potential o f these organisms.
Porins are an integral part o f  the cell membrane which permit free exchange of 
material between the bacterial cell and the external environment (176, 267). They usually 
exist as p-barrels with 3-strands that traverse the membrane and form channels with a 
diameter range o f approximately 1 run (176) and a size exclusion range o f 600 kDa to 
5000 kDa (267). Porins activate splenocytes (235) and IL-1 and IL-6 gene expression in 
human monocytes (76). Isolated porins from Salmonella typhi stimulate a protective 
immune response in rabbits by the induction of lymphokines leading to the activation of T- 
cells (80).
The major outer membrane protein (MOMP) present in the cell wall o f C. jejuni 
has been identified as a porin, with a calculated molecular weight of 43 kDa and its 
presence identified in approximately 60% of pathogenic strains o f C. jejuni (26, 31, 118). 
When the MOMP was purified and reconstituted in a lipid bilayer, it formed a channel
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with a conductance o f  8.82 nS in 1M KC1 (103). Conformational analysis of the porin 
protein showed it was a trimer formed by three folded monomers with a high degree of 13- 
sheet secondary structure (26). It is also immunologically similar to the OmpC protein in 
Escherichia coli (118) and classified as part o f the trimeric porin family (103).
I report the identification and characterization of a cytotoxic porin-LPS complex 
produced by C. jejuni. Although there have been several previous reports reviewed by 
Sears and Kaper (225) and Wallis (259) describing the production o f cytotoxins by C. 
jejuni, the present report is the first to identify a complex composed o f a porin protein and 
LPS. These findings may lead to a more comprehensive understanding of toxin-mediated 
enteritis in Campylobacter infections.
2.3 Materials and Methods
2.3.1 Bacterial strains and culture media.
Strain 2483 o f  C. jejuni was isolated from a patient with gastroenteritis and was 
characterized as Lior serotype 82, biotype 1 and Penner serotype 0 : 11. The organism 
was passed twice on tryptic soy agar containing 5% sheep blood (TSA) following isolation 
from the patient and was subsequently stored at -70°C in tryptic soy broth containing 5% 
sheep blood. Thawed aliquots were cultured on TSA with 5% sheep blood prior to 
inoculation into Brucella broth (BBL, Cockeysville, MD) pre-equilibrated in an 
atmosphere containing 5% O2, 10% CO2 and 85% N2. For batch preparation, a 
suspension o f the organism was made equivalent in density to a McFarland number 8 
standard and inoculated into 41 o f Brucella broth at a rate of 2 ml/1. Inoculated broths 
were incubated under stationary conditions in the gas mixture for 48 h at 37°C.
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2.3.2 Isolation of cytotoxic complex.
Bacteria were harvested by centrifugation at 12,000 x g for 20 min at 4°C and the 
4 liters o f  organism-free filtrate were concentrated by ultrafiltration at 4°C with a stirred 
cell apparatus using a YM30 membrane (30,000 NMWL) (Amicon, Beverly, Ma). The 
filtrate was initially concentrated approximately 40-fold by ultrafiltration and further by the 
addition o f ammonium sulfate to 80% saturation at 4°C. The ammonium sulfate 
precipitated proteins were collected by centrifugation at 12,000 x g for 30 min and 
resuspended in 50 mM Tris-HCl buffer, pH 7.0. Purification of the cytotoxic protein was 
performed using a Hewlett Packard 1050 series high performance liquid chromatograph 
(HPLC) equipped with a diode-array detector. Purification was initiated by adding 
concentrated filtrate at 1% of the total bed volume to a HGLoad™ 16/60 Superdex™ 75 
sizing column (Pharmacia Biotech, Uppsala, Sweden) and eluting with phosphate buffered 
saline, pH 7.0 (PBS) at a flow rate o f 1 ml/min. Fractions were collected on a Gilson 
fraction collector and 50 pi o f each were evaluated for cytotoxic activity using HEp-2, 
HeLa and CHO cells. The molecular mass o f the native cytotoxic complex was 
determined by calibrating the column using low molecular weight standards (Pharmacia 
Biotech) dissolved in PBS. Cytotoxic-containing fractions were pooled, concentrated 
using Centraprep-30 units (Amicon), and applied to a 7.5 X 75 mm TSK DEAE-5PW 
column (Pharmacia Biotech). Proteins were eluted using a linear gradient of 0.2-0.25 M 
NaCl in 50 mM Tris-HCl, pH 7.0 at a flow rate o f 1 ml/min. Fractions were collected, 
desalted by spin dialysis using Centricon-30 units (Amicon) and 50 pi o f each sample were
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applied to monolayers o f HEp-2, HeLa and CHO cells for assessment o f  cytotoxic 
activity.
The bacterial pellet removed from the filtrate was placed on ice and sonicated 
using a Bronson Sonifier 450 sonicator (Branson Ultrasonic Corporation, Danbury, CT), 
centrifuged at 12,000 X g for 10 min and the supernatant fluid assayed in the same manner 
as the filtrate.
2.3.3 Polymerase chain reaction.
Genomic DNA was isolated from C. jejuni strain 2483 by standard procedures 
(222). PCR was conducted as outlined previously (204) using 50 ng of genomic DNA 
with is. coli verotoxin VTla primers (GAAGAGTCCGTGGGATTACG) and VTlb 
(AGCGATGCAGCTATTAATAA) and VT2a (TTAACCACACCCACGGCAGT) and 
VT2b (GCTCTGGATGCATCTCTGGT) at 42°C, 45°C, and 50°C annealing 
temperatures. PCR was also conducted using primers DZ3 (AGTAAGGAGAA 
ACAATGA) and R009 (AATAAGCCTTAGAGTCTTTTTGGAATCC) specific for 
Helicobacter pylori cagA and primers F6 (GCTTCTCTTACCACCAATGC) and R20 
(TGTCAGGGTTGTTCACCATG) specific for H. pylori vacA gene as outlined previously 
(270). The H. pylori Penner reference serotypes 05 and 06 were used in PCR reactions as 
positive controls for the cagA and vacA respectively. The PCR methodology used was as 
described for cagA (270) except that 100 ng/reaction of chromosomal DNA were used for 
amplification o f the vacA gene using 35 cycles o f 95°C for 1 min, 58°C for 1 min and 
72°C for 2 min with a final extension o f 10 mm PCR reactions were electrophoresed on a 
1% agarose gel in Tris-acetate, EDTA-containing buffer (pH 8.3) (222), stained with
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ethidiumbromide and visualized on a transilluminator (Ultra-violet Products, Inc., San 
Gabriel, CA).
2.3.4 Cytotoxic activity and protein determination.
The amount o f  protein at each stage of the isolation procedure was quantified 
using the BCA protein assay (Pierce, Rockford, IL). HEp-2, HeLa and CHO cells were 
grown in T-75 cell culture flasks (Costar, Cambridge, MA) using Eagle’s minimal essential 
media (MEM) supplemented with 10% fetal bovine serum (FBS) (Sigma, St. Louis, MO). 
Cells were subcultured into 96-well plates (Costar) 24 h prior to determination of 
cytotoxic activity. Cytotoxic activity was quantified in the three cell lines as described 
previously (109) and activities expressed afier 48 h incubation as tissue culture dose 50 
(TCDso). A TCD50 was defined as the amount o f toxin required to cause cytotoxic 
changes in 50% of the cells. Cell cultures were fixed for 10 min in absolute methanol and 
stained for 30 min with Giemsa (Gibco BRL, Grand Island, NY). The specific activities 
were determined at each step o f  the isolation and expressed as TCDso/pg of protein. E. 
coli 0157:H7 strain LCDC 3787 (H19), positive for VT1, and strain LCDC 90-2380, 
positive for VT2, were used as controls for TCD50 determination in HEp-2 and HeLa 
cells. V. cholerae 01, strain 755, an enterotoxin-producing isolate, was used as a control 
in the CHO cell assay.
46
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
23.5 Molecular weight and physical characterization of the cytotoxic complex.
One pg of the isolated cytotoxic material was mixed with equal volumes o f 2X 
sample buffer containing (3-mercaptoethanol and sodium dodecyl sulfate (SDS) (222).
The sample was boiled for 5 min and separated by sodium dodecyl sulfate polyacrylamide 
gel electrophoresis (SDS-PAGE) on a 12% homogeneous gel along with low molecular 
weight standards and silver stained using a commercial kit (BioRad, Hercules, CA). One 
pg aliquots o f the isolated cytotoxic material were either heated at 70°C for 30 min or 
treated with trypsin in PBS at concentrations ranging from 0.03 to 1.25% for 2 h at 37°C. 
Residual trypsin activity was inactivated by addition of an equal volume of 20% FBS for 1 
h at 37°C. Heated and trypsin-treated samples were serially diluted 2-fold in PBS prior to 
cell culture assay to determine the degree o f activity remaining after the treatments. Heat- 
inactivated trypsin and FBS alone were used as negative controls.
2.3.6 N-terminal sequencing of cytotoxin.
The cytotoxic component was isolated and denatured with SDS and (3- 
mercaptoethanol and electrophoresed along with kaleidoscope prestained molecular 
weight standards (BioRad) on a 12% gel SDS-polyacrylamide gel electrophoresis 
(PAGE). Following electrophoresis, the protein and standards were electrophoretically 
transferred to polyvinylidene diftuoride (PVDF) (BioRad) for 18 h at 100 mA in 10 mM 3- 
[cyclohexylamino]- 1-propanesulfonic acid (CAPS) (Sigma) buffer, pH 11.0 containing 
10% methanol as previously described (145). Following transfer, the blot was stained 
with 0.1% Coomassie blue R-250 (BioRad) in 50% methanol for 5 min and destained with
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5 0 %  m e t h a n o l  and 1 0 %  acetic acid. The immobilized cytotoxic protein was excised from 
the PVDF and sequenced by Edman degradation on an Applied Biosystems model 473A 
protein sequencer (CHUL Research Center, Sainte-Foy, Quebec, Canada). Protein 
analysis was performed using Lasergene (DNAStar, Madison, WI).
23.7 Neutralization and Western blot analysis.
Neutralization studies were performed on 1 pg aliquots o f the isolated complex 
using polyclonal antisera raised against the cytotoxic complex from C. jejuni (lot #2667), 
as well as against E. coli VT1 (lot# 3075), E. coli VT2 (lot# 3076), CLDT from C. jejuni 
(lot# 2539) and CLDT fro m £  coli (lot# 2523) (109), enterotoxin from V cholerae 
(Sigma, lot# 114H4801) and the cytotoxin from C. difficile (Techlab, Blacksburg, Va, 
lot# 1094007). Normal rabbit serum was used as a negative control. Homologous 
antiserum was raised by intram uscular inoculation of New Zealand white rabbits with 0.5 
ml of a 5 pg/ml preparation o f isolated complex emulsified in 0.5 ml Freund's incomplete 
adjuvant. This was followed at weekly intervals for 4 weeks by subcutaneous injection of 
the same antigen preparation in Freund’s incomplete adjuvant. Al :10  dilution of each 
antiserum was added to serial two fold dilutions o f 1 pg o f the isolated protein. Alter a 1 
h incubation at 37°C, aliquots o f each were added to HEp-2 cells and incubated for 48 h at 
37°C. Each antiserum was also assayed using Western blot analysis. C. jejuni cytotoxic 
complex, E. coli VT1 and VT2, C. jejuni CLDT, E. coli CLDT, C. difficile cytotoxin and 
V cholera enterotoxin were each separated on SDS-PAGE gels along with kaleidoscope 
prestained molecular weight standards (BioRad) and transferred to 0.2 pm pore size 
PVDF membranes for 18 h at 100 mA. Membranes were washed with 5% skim milk for 1
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h to prevent non-specific binding of the antibodies and then washed 3 times for 5 min each 
with PBS. A  1:500 dilution o f each of the antisera in a 1% skim milk solution containing 
0.05% Tween-20 was prepared and added to the membranes for 2 h at room temperature. 
This was followed by a 1 h treatment with 200 mU/ml o f goat anti-rabbit alkaline 
phosphatase conjugated antibody (Boehringer Mannheim, Laval, Quebec, Canada) at 
room temperature. Membranes were developed using 5-Bromo-4-chloro-3-indolyl- 
phosphate (BCIP) and nitro blue tetrazolium (NBT) (Boehringer Mannheim).
Western blot analysis was also performed on crude concentrated filtrates from C. 
jejuni strain 2483, C. jejuni strain 3969, C. jejuni strain 16336, C. coli strain 8682, 
Aeromonas veronii strain A2297 and E. coli (VT1+) strain 3787 (19). The filtrates from 
A. veronii and E. coli were used as negative controls. A total o f 40 pg of each crude 
filtrate was electrophoresed and transferred to PVDF as stated previously and probed with 
anti-cytotoxic complex from C. jejuni strain 3969 (lot #2667). In addition, each filtrate 
was tested for cytotoxic activity in HEp-2 cells after 48 h o f incubation.
2.3.8 Carbohydrate characterization.
A total o f 2 pg of the isolated cytotoxic material was assayed for the presence of 
lipopolysaccharide by the Limulus amebocyte lysate (LAL) test according to the package 
insert (Pyrotell, Associates o f Cape Cod, Inc., MA). The toxic material was diluted 10- 
fold with pyrogen free water in duplicate and 100 pi o f each dilution were incubated with 
100 pi o f Pyrotell in a 37°C water bath for 1 h. Tubes were inverted and those containing 
a solid clot were considered positive. To determine whether the lipopolysaccharide 
contributes to the activity o f the toxin, 1 pg of the isolated cytotoxic material was
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incubated for 1 h at 37°C with 5 U neuraminidase (Sigma) at pH 5 .0 , 3 U of N- 
glycosidase F (Boehringer Mannheim) at pH 7.2 and 10 mM sodium meta-periodate 
(Sigma) for 90 min at room temperature. The residual cytotoxic activity was then assayed 
in HEp-2 and HeLa cells using serial two-fold dilutions. Identification o f the carbohydrate 
moiety was made using a glycan differentiation kit (Boehringer Mannheim) containing five 
unique digoxigenin-labeled lectins (Table 2.1). Approximately 1 pg o f the isolated 
cytotoxic protein and 5 pg o f each carbohydrate standard were spotted on PVDF 
membranes and allowed to dry overnight at 37°C. Membranes were probed for the co- 
purifying LPS according to the manufacturer’s instructions. Those lectins that gave 
positive results were further examined by Western blot analysis using 15 pg of each 
carbohydrate standard and 8 pg o f the test carbohydrate from the purified preparation.
The isolated cytotoxic material from three separate batches was assayed for carbohydrate 
concentration using a phenol-sulfuric acid assay measured at 4 9 0  nm (59 ). The 
concentration o f carbohydrate in pg was determined and expressed as a ratio for each pg 
o f purified protein in these preparations. SDS-PAGE and native PAGE were performed 
using 10 pg of the carbohydrate and gels were double stained, first with periodic acid- 
Schiff (PAS) (226) then with Coomassie blue.
2.4 Results
2.4.1 Identification and  molecular characterization of cytotoxic complex.
Early cytological signs o f intoxication caused by the cytotoxic complex included 
the formation o f vacuoles in the cytoplasm of both HEp-2 and HeLa cells. The number of
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Table 2.1. Specificities and the reactions of the lectins used in the carbohydrate determination.
Lectins Specificity (linkage) Reactivity*
Galanthus nivalis agglutinin (GNA) Mana(l-3), a (l-6 ) or a  (l-2)-Man 
(terminally linked mannose)
+++
Maackia amurensis agglutinin (MSA) Neu5Aca (2-3)-Gal (sialic acid terminally 
linked a2-3 to galactose)
+
Datura stramonium agglutinin (DSA) Gaip( l-4)GlcNac (galactose-P( l-4)-N- 
acetylglucosamine)
+
Arachis hypogaea (peanut) agglutinin (PNA) Gaip(l-3)GalNac (galactose-P(l-3)-N- 
acetylgalactosamine)
-
Sambucus nigra agglutinin (SNA NeuSAca (2-6)-Gal or GalNac (sialic acid terminally 
linked a(2-6) to galactose or N-acetylgalactosamine)
-
* +++ strong positive result
+ weak positive result
vacuoles in each cell ranged from 1 to 5 with 50% or more of the cytoplasm o f  some cells 
hemg affected. After 24 h, the vacuoles diminished in size and the cells developed a 
rounded, highly refractile appearance. Over the course o f the subsequent 24 h (i.e., from 
24 to  48 h), cytoplasmic blebbing and nuclear condensation become more evident along 
with cell loss from the monolayer. Toxicity appeared to be dose-dependent and was 
detected using 2-fold serial dilutions o f the isolated material (Fig 2.1) At the lower 
cytotoxin concentration of 1 pg o f protein/well (Fig 2. IB), the vacuoles persisted up to 48 
h while rounding occurred up to 72 h as compared to the control (Fig 2.1 A) When higher 
cytotoxin concentrations o f 10 pg protein/well were used; vacuoles formed and dissipated 
within the first 12 h following intoxication and greater than 50% of the cells were rounded 
and refractile by 24 h. By 48 h, 80-100% of the cells had become rounded (Fig 2.1C). 
Similar cytological changes were observed in all o f  the cell lines when the whole bacterial 
cell sonicate was assayed for toxicity. Strain 2483 produced low levels of CLDT in the 
crude concentrate in the fractions from the G75 column purification, however this could 
be neutralized with polyclonal antisera raised against C. jejuni and E. coli CLDT (data not 
shown). However, no residual CLDT activity was observed in the DEAE purified 
fraction.
The organism s were grown for 48 h at 37°C in Brucella broth at which time the 
bacteria were in the stationary growth phase as determined by viable colony counts. 
Concentrated proteins possessing high levels o f cytotoxic activity were found to elute 
from the G75 column in the void volume (Fig 2.2, peak A) with a calculated native
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*Figure 2.1.
Morphological changes induced in HEp-2 cells after 48 h treatment with C. jejuni 
cytotoxic porin-LPS complex. (A) control (magnification 85X); (B) 1 pg of isolated C. 
jejuni cytotoxic complex (magnification 85X); (C) 10 pg o f isolated C. jejuni cytotoxic 
material (magnification 80X ). Insert is of a single HEp-2 cell (magnification 175X).
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molecular mass o f greater than 100 kDa. This peak was collected and applied to the TSK 
DEAE-5PW column. Cytotoxic activities of the TSK DEAE-5PW fractions showed the 
toxin eluted at approximately 0.21-0.22 M NaCl (Fig 2.3). The two-column purification 
procedure produced a single silver-stained protein with a molecular size o f 45 kDa 
calculated by R/  under denaturing conditions (Fig 2.4). The specific activities at each 
stage o f the purification procedure are shown in Table 2.2. The isolated cytotoxic 
complex had the highest specific activity in HEp-2 cells and the lowest in CHO cells. The 
cytotoxin was inactivated by heat treatment at 70°C for 30 min but was resistant to trypsin 
at the concentrations tested.
Oligonucleotide primers specific for £. coli VT1 and VT2 failed to produce 
amplicons corresponding to A- and B-subunits o f  mature verotoxin types 1 and 2 at the 
various annealing temperatures. Also, primers specific for the cagA and vac A genes o f H. 
pylori failed to generate amplicons.
2.4.2 Protein Alignment.
The cytotoxic protein-LPS complex consisted o f a single protein with a calculated 
molecular mass o f 45 kDa. The excised band was subjected to N-terminal sequencing and 
a total o f 31 ammo acid residues were elucidated (Table 2.3). The protein was found to 
contain several hydrophobic and charged residues and had a predicted isoelectric point o f 
4.35. The protein had 97% homology with the major outer membrane protein (MOMP) 
from C. jejuni which has been characterized as a porin (26) and the single amino acid 
difference at residue 30 was conserved. The cytotoxic porin also shared 56% and 63%
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Figure 2.2.
Elution profile o f the cytotoxic complex. (A) Ammonium sulfate precipitated 
proteins were applied to a G75 gel filtration column and cytotoxic activity was found in 
the void volume. +++, >70% cell rounded by 48 h, ++ 50-70% cell rounded by 48 h, +, 
<50% cell rounded by 48 h
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Figure 2.3.
Peak A from the G75 column was collected and applied to TSK DEAE-5PW 
column and eluted with a linear gradient o f NaCl from 0.2 M to 0.25 M and cytotoxic 
activity was found in peak. +++, >70% cell rounded by 48 h.
56
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
1 2 3
Figure 2.4.
Silver stained SDS-PAGE after TSKDEAE-5PW column. Lanes 1 and 3: low 
molecular weight standards (kDa) (BioRad); Lane 2: 1 pg o f C. jejuni isolated cytotoxic 
porin-LPS complex.
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sequence homology with 45 kDa and 51 Kda outer membrane proteins respectively from 
Wolinella recta (117).
2.4.3 Neutralization and Western blot analysis.
Polyclonal antisera raised against E. coli VT 1 and VT 2, C. jejuni and E. coli 
CLDT, V cholerae enterotoxin and C. difficile cytotoxin failed to neutralize the cytotoxic 
effects elicited by the C. jejuni toxic complex in cell culture. However, when this 
cytotoxic complex was serially diluted, incubated with homologous rabbit polyclonal 
antiserum and added to HEp-2 cells, the TCDso was 1:2 whereas cytotoxin incubated with 
normal rabbit serum had a TCDso of 1:32. Neutralization was defined as a decrease in the 
TCDso at 24 h post-intoxication. Homologous antiserum also showed immunological 
reactivity with the purified 45 kDa cytotoxic protein but not with the high molecular 
weight carbohydrate component. Antisera raised to the other toxins showed no cross 
reactivity with either the cytotoxin or carbohydrate on Western blot analysis (Data not 
shown). Western blot analysis using crude concentrated filtrates from various cytotoxic 
strains of Campylobacter sp and antiserum raised against the porin-LPS complex, revealed 
an immunologically similar protein with a molecular mass comparable to that o f the porin 
(Fig 2.5). However, this immunologically similar protein was not present in filtrates o f A. 
veronii and E. coli.
2.4.4 Lipopolysaccharide identification and carbohydrate analysis.
The isolated cytotoxic material was assayed for the presence o f endotoxin by 
incubating serial dilutions with Limulus amebocyte lysate for 1 h at 37°C. The cytotoxic
58
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Table 2.2. Specific activities expressed as TCDWug o f protein at each step o f the isolation 
procedure for the cytotoxic complex from C. jejuni and the toxin control strains in HEp-2,
HeLa and CHO cells.




C jejuni crude concentrate 1.56 0.51 0.51
C jejuni Superdex 75 16/60 1.61 3.88 0.97
C jejuni TSK DEAE-5PW 20.1 7.49 1.87
E. coli VT1+ 0.35 0.17 ND
E. coli VT2+ 1.48 2.89 ND
V cholerae O l ND N D 0.48
* TCDso/pg o f  protein 
ND not determined
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Table 2.3. Sequence homology o f the C. jejuni 2483 cytotoxic protein and other sequence 
available in BLAST; (Beckman Center for Molecular and Genetic Medicine, Stanford 
University o f  Medicine). Capital letters represent identical residues; “*” represent conserved 
changes; represents mismatch in sequences; “X” represents unknown residue.
Protein designation Sequence Ref
C. jejuni cytotoxic protein TPLEEAIKDVDVSGVLRYRYDTGNFDKNFVN
C. jejuni MOMP; porin protein TPLEEAIKDVDVSGVLRYRYDTGNFDKNF*N (5)
W. recta 45 kDa OMP T P L E E A IK D V D -SG ------Y X Y - * - - - X - N - - (19)
W. recta 51 kDa OMP T P L E E A IK *V D *S G - -X Y X Y *---------- KN- - (19)
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Western blot analysis using antiserum against the porin-LPS complex with 40 pg 
of crude, concentrated filtrate from Campylobacter sp. Lanes 1 and 9: Prestained 
standards (kDa) (Gibco BRL); Lane 2: uninoculated broth; Lane 3: Aeromonas veronii 
strain A2297; Lane 4: C. coli strain 8682; Lane 5: C. jejuni strain 16336; Lane 6: C. 
jejuni strain 3969; Lane 7: C. jejuni strain 2483; Lane 8: E. coli (VT1+) strain 3787.
61
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
material produced a strong positive result at a dilution o f 1:128,000 signifying that the 
isolated cytotoxic material contained LPS. To determine which part o f the complex was 
responsible for the cytotoxic activity observed in tissue culture, the complex was 
incubated with 10 mM sodium meta-periodate, to oxidize the free hydroxyl groups present 
on visceral hexoses, with 5 U  neuraminidase, to cleave sialic acid residues and with 3 U N -  
glycosidase F to cleave asparagine bound N-glycans. The complex was then assayed for 
cytotoxic activity in HEp-2 and HeLa cells. Titers o f 1:32 were observed for each o f the 
test wells in HEp-2 cells while a titer o f 1:8 was found for each of the wells in HeLa cells 
which were both equivalent to  the control w ell The difference in toxicity titers observed 
between the HEp-2 and HeLa cells was consistent with previous findings by McSweegen 
and Walker (154).
The carbohydrate component of the LPS was characterized using digoxigenin- 
labeled lectins (Table 2.1) and the data revealed a complex of different subunits. Lectin 
Galanthus nivalis agglutinin (GNA) reacted strongly with the purified material and 
suggested a high proportion o f  terminally-linked mannose. The lectins Maackia 
amurensis agglutinin (MAA) and Datura stramonium agglutinin (DSA) also gave positive 
but weaker results, indicating the presence o f sialic acid terminally linked a(2-3) galactose 
and galactose-P(l-4)-N-acetylghicosamine in the complex as well as hybrid N-glycan 
structures. The remaining lectins showed no reactivity for the carbohydrate complex. The 
proportion o f carbohydrate to  protein in the purified material was calculated at a ratio of 
4:1. PAS staining revealed a high molecular weight carbohydrate which did not appear as 
a discrete band as did the protein component o f the complex but, instead, occupied a
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broad range of sizes (Fig 2.6). Double staining o f purified cytotoxin in native PAGE gels 
showed no protein component (Fig 2.7, lane 2) in contrast to samples boiled in denaturing 
buffer prior to gel electrophoresis (Fig 2.6, lane 3) showing the importance o f denaturing 
the sample prior to electrophoresis in order to resolve the protein component o f the 
complex. Western blots performed with the lectins showed that the high molecular mass 
smear seen following PAS staining (Fig 2.7) was carbohydrate in nature with high 
reactivity for GNA (Table 2.1).
2.5 Discussion
A cytotoxin from strains o f C.jejuni that was heat-labile, trypsin-sensitive and 
induced rounding o f HEp-2, HeLa and MRC-5 cells was first documented by Yeen et al. 
(273). Guerrant et al. (85) also described a cytotoxic component which was heat labile at 
60°C, was partially sensitive to 0.25% trypsin and had a molecular weight greater than 14 
kDa. The cytotoxic component identified by these workers could not be neutralized using 
antisera raised against E. coli verotoxins or C. difficile toxin (85). A subsequent report 
indicated the presence o f a Shiga-like cytotoxin from C.jejuni which could be neutralized 
with monoclonal antibodies directed against the B subunit o f the mature Shiga-toxin; 
however, these workers also detected a cytotoxin which could not be neutralized by the 
same monoclonal antibody (167). In addition, Guerrant and colleagues (85), unlike Yeen 
et al. (273), found cytotoxic activity in sonicated whole bacterial cell preparations. In the 
present study cytotoxic activity was detected in both culture and sonicated filtrates from 
whole bacterial cells.
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1 2 3 4
Figure 2.6.
Double staining ofnative-PAGE and SDS-PAGE with periodic acid SchifF(PAS) 
and Coomassie blue to detect the carbohydrate moieties and the protein component o f the 
C. jejuni isolated cytotoxic porin-LPS complex. Lane 1: native low molecular weight 
standards; lanes 2: 10 pg of carbohydrate co-purifying with C. jejuni isolated cytotoxic 
porin-LPS complex run under native conditions; Lane 3: 10 pg of carbohydrate co- 
purifying with C. jejuni isolated cytotoxic porin-LPS complex run under denaturing 
conditions: Lane 4 :. kaleidoscope prestained standards (kDa) (BioRad);
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Figure 2.7.
Western blot analysis of the isolated cytotoxic complex with the lectin GNA. 
Lanes 1 and 4: kaleidoscope prestained standards (kDa) (BioRad); Lane 2: 10 pg of 
carbohydrate co-purifying with C. jejuni isolated cytotoxic porin-LPS complex; Lane 3 
15 pg carboxypeptidase Y.
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Ia the preseat study, a cytotoxic complex containing a porin and LPS was isolated and 
characterized. Previous studies showed a cytotoxic factor present in LPS-rich fractions 
from C. jejuni (166); however, it was not known what role the LPS played in toxicity. 
Currently, no N-terminal sequence information is available from any of the published 
cytotoxins produced by C. jejuni. As a consequence, an accurate comparison cannot be 
made concerning the nature o f  the cytotoxin other than to define the morphologic changes 
induced in cell culture and the susceptibility to trypsin and heat treatments. Misawa et al. 
(163) found that the expression o f their cytotoxin was elevated when the C. jejuni was 
grown in Brucella broth. However, contrary to the findings o f  these workers, it was 
determined here that HEp-2 cells showed the highest sensitivity to the cytotoxic complex 
and that these activities were consistently higher whether or not the cell cultures were 
grown in media supplemented with FBS (163). The increase in activities observed in the 
different cell lines could be due to the relative amounts o f the receptor required for binding 
of the porin-LPS complex. Reports have implicated LPS in adhesion of C. jejuni to 
epithelial cells which could be inhibited by periodate oxidation (154). Since the cytotoxic 
activity o f the porin-LPS was maintained following treatment with periodate in both HEp- 
2 and HeLa cells, it would appear that adhesion of the toxic complex is facilitated by 
components other than LPS. It is possible that expression o f the porin protein may be 
involved in binding the organism to host cells; however, Fauchere et al. (65) indicated that 
the MOMP was not involved in adherence to HeLa cells. From these studies it would 
appear that, although the LPS mediates attachment o f organisms to host cells (154), the 
porin component binds the cytotoxic complex.
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Although the mode of action o f  the cytotoxic porin remains unclear, the 
moiphological changes induced by it are similar in nature to other well-characterized 
bacterial cytotoxins. During early stages o f intoxication the cytotoxic porin induced 
vacuole formation in HEp-2 and HeLa cells and this was similar in appearance to those 
produced in response to Helicobacter pylori vacuolating toxin (265). Although 
vacuolation following intoxication with C. jejuni cytotoxin has been reported in 
hepatocytes (163), no PCR products were generated with primers specific for cagA and 
vacA genes suggesting that the genes encoding for the vacuole induction by the C. jejuni 
porin are unique from the genes carried and expressed in H. Pylori.
When intoxication of host cells with the C. jejuni cytotoxic porin was extended 
beyond 24 h, vacuoles dissipated while the cytoplasmic blebbing and nuclear condensation 
typical o f verotoxin and diphtheria toxin became more evident. Verotoxin and diphtheria 
toxin are both known to interfere with protein synthesis leading to programmed cell death 
or apoptosis (45, 105). PCR-based screening o f C. jejuni using verotoxin-specific primers 
was negative and confirmed the low stringency hybridization experiments of Moore et al. 
(167) which suggest that the C. jejuni cytotoxic complex was distinct from verotoxin.
This cytotoxic complex was able to induce DNA fragmentation in HEp-2 cells indicating 
that cells could be apoptotic. However, this presentation did not occur in Vero cells. It is 
possible that the porin from C. jejuni induces holes in the cell membrane in a manner 
similar to that resulting from Staphylococcus aureus a-toxin (45). This latter toxin has 
also been shown to induce an apoptotic reaction. Recently, the cytotoxic effects elicited 
by S. typhimurium porin suggested that porins directly effect the cytoskeleton and the
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membrane ultrastructure o f HEp-2 cells (54). In addition, porins from Neisseria sp. have 
also been shown to inhibit polymerization o f actin in human neutrophils (23) while porins 
from S. typhimurium have been found to  induce both an inflammatory response (77) and 
the release o f  cytokines from human monocytes and lymphocytes (75).
Attempts to determine the isoelectric point o f the cytotoxic protein by Coomassie 
blue staining and probing by Western blots of isoelectric focusing (IEF) gels with antisera 
raised against the complex were unsuccessful. This could be due to the tight complex 
formed between the protein and LPS which could not be disrupted with the non-ionic 
detergent, Nonidet P-40. Isolation o f the cytotoxic porin protein using a 
chromatofocusing column and polybuffer 7-4 (Pharmacia Biotech) was difficult to 
reproduce due to probable interference from LPS as well. The isolation protocol was also 
applied to a cell-free filtrate from C. jejuni strain 3969 which had previously been reported 
to produce a cytotoxin (108, 163, 164). Although the strain produced a lower cytotoxic 
activity, similar morphological changes were observed in HEp-2 cells and a protein of 
similar size was observed following SDS-PAGE. A protein o f comparable molecular 
weight was also present in crude concentrated filtrates from other cytotoxic strains of 
Campylobacter sp., indicating that the release of the porin-LPS complex is not unique to 
C.jejuni strain 2483. Carbohydrates were also present in the cytotoxic product isolated 
from C. jejuni strain 3969. Although this strain was untypeable with available Lior 
antisera, it proved to be a biotype 1, Penner serotype 0:50. The differential in cytotoxic 
activity between strain 3969 (low toxin activity) and 2483 (high toxin activity) could be a 
growth-rate dependent phenomenon since the release of the porin-LPS complex may
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occur most avidly doling cell death or may be lost during active replication o f the 
organism. Strains with a higher growth rate could therefore produce quantitatively more 
complex (156). Recently a vacuolating cytotoxin similar to  that produced by H. pylori 
was detected in the stools of children with diarrhea, even though no etiologic diarrheal 
agent was identified (80). Although many organisms have been shown to induce vacuole 
formation, this process may be porin-mediated following release from dead or dying 
organisms (156).
Lectin studies showed that the carbohydrate portion o f the LPS which co-purified 
with the porin possessed terminally-linked mannose and sialic acid terminally linked a(2-3) 
to galactose as well as galactose-P( l-4)-N-acetylglucosaniine complexed together with 
hybrid N-glycan structures. Based on the thermostable somatic (0 ) antigen, the strain of 
C. jejuni used in this study was type 0 : 11. The chemical composition of the LPS of this 
serotype is currently under investigation in collaboration with Dr. Malcolm B. Perry of the 
National Research Council in Ottawa. The positive result with the lectin MAA suggests 
that the strain may be related to serotypes 0:2 or 0 :4  (10, 11). The LPS from the 0:2 
and 0 :4  serotypes of C. jejuni have core structures that mimic those present on Gmi and 
Gougangliosides and have been linked to post infectious neuropathies (8). The presence 
o f terminally-linked mannose may be unique to the LPS from selected serotypes o f C. 
jejuni. Treatment of the isolated complex with sodium meta-periodate, neuraminidase and 
N-glycosidase F had no effect on the toxicity elicited by the complex, suggesting that the 
LPS is not an integral component o f the cytotoxic activity but that it may play a protective 
role. Indeed, it is possible that it may have interfered with the enzymatic degradation by
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trypsin and may offer an explanation for the disparity in trypsin inactivation data o f  
previous reports. To address this disparity, the complex could first be treated with the 
glycosidases followed by trypsin to see if  this permits degradation by first removing the 
carbohydrate moieties and exposing the protein component. Under native conditions, the 
LPS likely forms complexes with the porin and protects it from discrete staining with 
Coomassie blue. The cytotoxic protein is only revealed by Coomassie blue or silver 
staining after boiling in sample buffer containing SDS and P-mercaptoethanol prior to 
SDS-PAGE. Since the porin from C. jejuni has been classified as part o f the trimeric 
porin family, it was not unexpected that it must be heat denatured in order to resolve the 
protein component of the cytotoxic complex (176).
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SECTION m
Localization and DNA sequencing of porin gene from 
Campylobacter jejuni
3.1 Abstract
Campylobacter jejuni is a frequent enteric pathogen which causes diarrheal disease 
in developing and underdeveloped countries. Several pathogenic mechanisms have been 
postulated for the organism resulting in disease and these include adherence of the 
organism to gut cells followed by intracellular replication. In addition, several exotoxins 
have been attributed to the pathogen, hi this study, a porin-lipopolysaccharide complex 
was identified from C. jejuni strain 2483. Degenerative primers from the sequenced 
cytotoxic porin protein were synthesized and using a combination o f vectorette 
polymerase chain reaction (PCR), cloning and inverse PCR, a 1.45 kilobase (kb) fragment 
of DNA was sequenced and found to have a single open reading frame containing the 
corresponding N-terminus of the sequenced cytotoxic porin protein. The porin gene, 
designated porA, consisted o f a 1275 bp open reading frame encoding a 45.6 kDa protein 
with a calculated p i o f 4.35. The protein possessed a 22 amino acid leader sequence. The 
translated protein had a 50% sequence similarity with Haemophilus influenzae major 
outer membrane protein P2 but showed only 23% sequence identity. A total o f 32 strains 
o f Campylobacter sp. and related organisms were screened by PCR for porA and tested
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for expression o f a cytotoxin in cell culture using HEp-2 cells following growth of the 
organisms in a biphasic system. Twenty-one o f  the 32 strains (66%) were genotypically 
positive for the cytotoxic protein gene and of these 21 o f 23 (91%) were C.jejuni strains 
suggesting that the porin gene was highly conserved. All 32 o f the strains examined 
(100%) were phenotypically positive for a cytotoxin when their filtrate were assayed for 
toxicity in tissue culture using HEp-2 cells.
3.2 Introduction
Campylobacter jejuni is recognized as a cause o f bacterial-induced diarrhea in 
both developing and underdeveloped countries (230). Active surveys conducted in the 
United States have estimated the number of cases of campylobacteriosis to be 2.5 million 
per year making it a multi-million dollar disease (230). Symptoms caused by C. jejuni can 
range from watery to bloody diarrhea (172, 230). In most cases campylobacteriosis is a 
self-limiting disease but in the more severe cases, antibiotic intervention with macrolids or 
fluoroquinolones or rehydration therapy is necessary to eradicate the infection (172).
The organism has been reported to possess several virulence factors that may be 
responsible for disease (65, 166, 239) but little is known regarding the genetic processes 
that surround their production One virulence factor, a toxin has been cloned and 
sequenced successfully and this is the cytolethal distending toxin (CLDT) of C. jejuni 
(202). The CLDT operon was found to contain three open reading frames (ORF) 
designated cdtA, cdtB and cdtC and these correspond with 30.1-, 28.9- and 21.1-kDa 
proteins respectively (202). Escherichia coli minicell experiments have shown that all 
three genes are necessary for the production o f the active toxin. Screening of multiple
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strains o f Campylobacter sp. by polymerase chain reaction (PCR) for the presence o f the 
cdtB gene and HeLa cell assays for the expression o f CLDT revealed that all the strains 
tested carried the gene and tested positive in the cell culture assay (202). Johnson and 
Iio r (109) originally reported that 41% o f 718 isolates of Campylobacter sp. screened for 
the production o f CLDT were positive; however, isolates screened for the cdtB gene 
suggested that this percentage may be higher than was previously reported (109, 202). 
Genetic studies involving the production o f an enterotoxin by C. jejuni revealed DNA 
similarities between a postulated GMi binding site on the toxB gene from Vibrio cholerae 
and the E. coli heat-labile enterotoxin (eltB) gene. Despite this an enterotoxin gene has 
not been successfully cloned and sequenced from C. jejuni (36).
C. jejuni has a genome estimated to be 1.7 Mb in size as determined by pulsed 
field gel electrophoresis (PFGE) (246) while the % mol guanidine+cytosine ranged 
between 29-36 mol % ( 244, 246) The organism has the capability to transform free DNA 
as well as to be transduced by bacteriophages and to transfer DNA between strains by 
conjugation (207,248). These genetic exchange mechanisms could naturally facilitate the 
spread of antibiotic resistant determinants between strains (248) and may allow for the 
acquisition o f toxin genes (182). A number of genes have been sequenced from C. jejuni 
(Table 1.3) (244); however, the majority o f these take the form of highly conserved or 
“housekeeping” genes such as serine hydroxylmethyltransferase iglyA) (42) and y- 
glutamyl phosphate reductase gene (proA) (149). In addition, genes such as JlaA and JlaB 
encoding fiagella proteins (86) and peb4A, an antigenic surface protein (31) have been 
cloned and sequenced. Difficulties such as gene instability and failure to express
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functional products have been encountered and this has made genetic analysis of C. jejuni 
problematic (202,244).
Several porin genes from various bacterial species have been purified, cloned and 
sequenced (39, 81,90, 91, 169). Porins usually exist as a single, monomeric protein (90, 
176) or as homotrimers (26, 39) and possess a range o f pore sizes (26, 91). Porins are 
functional components o f the outer membrane o f bacteria which allow for exchange of 
solutes as well as permit the excretion o f waste products. One characterized porin from 
E. coli has been found to occur at a frequency o f 10s on each bacterial cell (169, 267) 
making it the most abundant molecule present on the cell surface (209, 267). Porins have 
also been found to induce morphologic changes in HEp-2 cells as a result o f alterations in 
the cytoskeleton following incubation with increasing concentration of the purified protein 
(54). Characterization of the protein with respect to its pore capabilities has already been 
reported (103). The genetic sequence and comparative analysis of the porin gene, porA, 
from C. jejuni is reported here together with data from the examination o f  32 strains of 
Campylobacter sp. and related organisms for the presence of this gene. This is the first 
study to provide information regarding the genetic sequence and the composition of the 
translated porin protein.
3.3 Materials and Methods
3.3.1 Bacterial Strains and Media.
C. jejuni, strain 2483, was isolated from a patient with gastroenteritis (150, 151) 
and was used for the localization and sequencing o f the porin gene. The organism was 
passed twice on tryptic soy agar containing 5% sheep blood (TSA) following isolation
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from the patient and was subsequently stored at -70 ° C in tryptic soy broth containing 5% 
sheep blood. Strains o f Campylobacter sp. and related organisms were maintained at - 
80°C in giycerol-p eptone water as part o f  the reference collection at the Laboratory 
Centre for Disease Control, Ottawa Canada.
3.3.2 Generation of Vectorette libraries.
Genomic DNA from C. jejuni strain 2483 was purified as described previously 
(152). A total o f 15 pg o f  genomic DNA was digested for 2 h at 37°C with 120 U of 
BairiHL, EcdRI, Nhe I, Spe I, Hind m , Bgl IT and Bel I restriction enzymes (Boehringer 
Mannheim, Laval, Quebec, Canada). The vectorette oligonucleotides, vectorette universal 
primer and degenerate primers were synthesized on an Oligo 1000M DNA synthesizer 
(Beckman, Fullerton, Ca.) and are listed in Table 3.1. Common linkers were allowed to 
anneal as outlined previously (213) by adding 10 mM concentration o f each 
dephosphorylated 57-mer top strand with the 53-mer bottom strand (3’-VP) at 65°C for 2 
min followed by cooling to 37°C over the next 20 min. A 30 pi ligation mixture was made 
with each digest containing 2.5 pg o f digested genomic DNA, 1 pi o f  annealed common 
linkers (with the corresponding compatible ends; Le. BamHI digested genomic DNA with 
5’-BamHI-), 1 mM adenosine triphosphate (ATP), 10 U T4 DNA ligase (Boehringer 
Mannheim) and 10 mM dithiothreitol (DTT). Each reaction was incubated overnight at 
15°C (Fig 3.1).
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Aigpgtprf genomic DNA annealed common linker
ligate common linkers to genomic DNA and PCR 
amplify with universal vectorette primer and 
oligonucleotide (p-3F) generated from N-terminal of 
porin protein
universal vectorette primer




->■ excise band and DNA 
sequence
Figure 3.1. Schematic diagram o f vectorette PCR.
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3.3.4 Polymerase chain reaction of vectorette library and inverse PCR.
Primers p-lF, p-2F and p-3F were generated from the sequenced amino-residues 
(26, section 2.4.2) number 23 to 29, 21 to 27 and 4 to 10 respectively. Design o f the 
primers was aided by a codon usage chart available through Genebank. Three separate 
PCR reaction mixtures were prepared by adding 1 pM of each degenerative primer (Table 
3.1) with 1 pM universal vectorette primer (UVP), 100 pi 10X PCR buffer (500 mM KCL, 
100 mM Tris-HCl (pH 8.3), 1% Triton X-100, 30 mM MgCk), 200 pi o f  a stock solution 
containing 200 mM of each deoxynucleotide triphosphates (dNTP), and 20 U Taq DNA 
polymerase (Promega, Madison, WI). The final volume was raised to 1 ml with sterile 
double distilled water (ddHjO). Five microliters o f each ligation mixture were added to 
50 pi o f each o f the PCR reaction mixtures followed by amplification in a PE9600 
thermocycler (Perkin-Elmer, Foster City, Ca.) with initial melting temperature set at 95°C 
for 2 min followed by 35 cycles at 95°C for 30s, 55°C for 30s and 72°C for 2 min with a 
final extension at 72°C for 2 min. The PCR reactions and a 100 bp ladder (Gibco BRL, 
Grand Island, NY) were electrophoresed on 1% low melting point agarose (LMP) (Gibco 
BRL) in IX Tris acetate, EDTA buffer at pH 8.4 and stained with 0.5 pg/ml ethidium 
bromide (Sigma) for 30 min. PCR products were excised from the agarose and extracted 
using the Promega PCR Preps DNA purification system (Promega).
Inverse PCR was performed by first adding 2.5 pg o f Hind HI digested genomic 
DNA with 6 pl o f 100 mM DTT, 6 pl o f 10 mM ATP, 5 U of ligase (Boehringer 
Mannheim), 6 pl o f ligase buffer (Boehringer Mannheim) and sterile dcffkO to give a final
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volume o f 60 pl (Fig 3.2). The mixture was allowed to ligate overnight at 15°C. 
Following Hgation, PCR was performed as stated above using p-3F and p-7R primers 
(Table 3.1) for 35 cycles. The PCR reaction was run on a 1% low melting point (LMP) 
gel and stained with ethidhim bromide. Amplicons were extracted with Promega PCR 
Preps DNA purification system (Promega) and DNA sequenced. The amplicons were 
DNA sequenced on an A B I377 automated DNA sequencer (Applied Biosystems, Foster 
City, Ca) using the Prism dye terminator cycle sequencing kit (Applied Biosystems).
DNA sequence analysis was performed using Sequencher 3.0 (Gene Codes Corporation, 
Ann Arbor, MI) and PC/Gene (Intelligenetics, Mountain View, Ca.).
3.3.4 Southern blot analysis of genomic DNA.
A total of 5 pg o f  C. jejuni strain 2483 genomic DNA was digested overnight at 
37°C with 20 U o f each restriction enzymes (section 3.3.2). Prior to electrophoresis, 
Hind ID digested lambda DNA was labeled with digoxigenin-1 l-uridine-5’-triphosphate 
using a random labeling kit (Boehringer Mannheim) for 1 h at 37°C. Digested DNA was 
electrophoresed on a 1 % agarose gel (Gibco) in IX TAE buffer together with the Hind 
m  digested lambda DNA ladder (Boehringer Mannheim). Following gel electrophoresis, 
the gel was Southern blotted using established procedures (222) by first placing the gel in 
denaturing solution (0.5 M  NaOH, 1.5 M NaCl) for 1 h at room temperature on an orbital 
shaker followed by 1 h in neutralizing solution (0.5 Tris-HCl, pH 7.5, 1.5 M NaCl) under 
the same conditions. The genomic DNA was transferred to Hybond-N+ nylon membranes 
(Amersham, Arlington, Heights, 1L.) using a Posiblot system at 75 mm Hg for 90 min
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1HindTK digested genomic DNA
circularize fragments with T4 DNA 
ligase overnight
PCR amplify with p-3F and p-7R
 ► p-3F
 > p -7 R
I electrophorese PCR amplicon
1500 bp
600 bp
extract 800 bp amplicon 
and DNA sequence
Figure 3.2. Schematic diagram o f the inverse PCR procedure.
80
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
(Stratagene, Aurora, Ontario, Canada). After transferring, the membrane was washed 
once with 2X sodium chloride solution containing sodium citrate (SSC) before being UV 
cross-linked in a UV Stratalinker 2400 (Stratagene). Cross-linked membranes were 
placed in 10 mlprehybidization solution (Gibco BRL) for 1 h at 55°C. The PCR amplicon 
generated from the p-3F and p-6R primers (Table 3.1) was extracted from a 1% low 
melting point agar (LMP) and 10-25 ng was digoxigenin-labeled using a PCR digoxigenin- 
labeling kit (Boehringer Mannheim). The PCR method was similar to that used for the 
vectorette PCR except that 15 cycles were used instead of 35. Approximately 50 ng of 
the lambda ladder probe and the digoxigenin-labeled cytotoxic protein probe were heat 
denatured at 100°C for 10 min, placed on ice for 5 min and then added to the 
hybridization solution at 55°C overnight.
Following hybridization, the membrane was washed twice for 15 min each in 2X 
SSC in 0.1% SDS at room temperature followed by two 15 min washes first at 55°C in 
IX SSC in 0.1% SDS and then 0. IX SSC in 0.1% SDS at room temperature. The 
washed membrane was blocked in 5% blocking reagent (Boehringer Mannheim) for 1 h on 
an orbital shaker prior to the addition o f anti-digoxigenin antibody conjugated to alkaline 
phosphatase (Boehringer Mannheim) used at a dilution of 1:5000 for 1 h. The membrane 
was washed 3 times for 5 min each in low salt Tris-bufFered saline (TBS) and placed in a 
1:20 dilution of CPD-Star lumigen substrate (Tropix, Bedford, Ma) in washing buffer 
containing 0.1M Tris-HCl at pH. 9.5, 0.1 M NaCl and 50 mM MgCk for 5 min. The 
membrane was exposed to high performance autoradiography film (Hyperfilm-MP) 
(Amersham) until a suitable band intensity was achieved.
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3.3.5 Cloning and DNA sequencing of porin gene.
The region o f  the genomic DNA digested with Spe I which reacted with the 
cytotoxic probe, was excised from a subsequent LMP gel, and extracted using Geneclean 
(Biol 101, LajoHa, Ca). To determine the optimal concentration o f insert to vector, 
various concentrations o f inserts were ligated to SO ng o f Xba I digested and alkaline 
phosphatase (Promega) treated pUC 19 (Pharmacia Biotech, Uppsala, Sweden) with 2.S 
U o f T4 DNA ligase and 1 mM ATP (Promega) at 15°C overnight. A total of 50 ng of 
vector was used to transform Epicurian coli XLl-bhie competent cells as outlined by the 
manufacturer (Stratagene) and 100 pl was plated on Luria broth (LB) agar plates 
containing 200 pg/ml ampicillin. For color development, plates were covered with 50 pl 
halogenated indolyl-3-D-galactoside (Bhio-gal) at 20 mg/ml (Gibco BRL) and 15 pl 
isopropylthio-P-galactoside (IPTG) used at 0.5 M (Gibco BRL). These were allowed to 
dry prior to the addition o f transformants.
Transformants were picked from the plates and grown overnight in 3 ml of LB 
with 200 pg/ml ampicillin. Plasmid preps were performed on 1.5 ml of culture using the 
Promega miniprep DNA purification system (Promega). A total o f 50 ng o f purified 
plasmid from the Spe I  ligation was added to 50 pl PCR mixture containing p-3F and p-6R 
and amplified for 20 cycles using the same methodology outlined above (section 3.3.3). 
Reactions were electrophoresed on a 1% agarose gel in TAE buffer and stained with 
ethidiuin bromide. Plasmids from positive clones were sequenced as described above 
(section 3.3.3) using the primers described in Table 3.1. PCR was performed on genomic 
DNA using primers p-15F and p-16R using the same method as for the porin probe.
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3.3.6 Screening of C  jejun i isolates for porin gene and cytotoxin production.
A total o f  32 strains o f C. jejuni and related organisms, including strain 2483 
(Table 3.2), were grown on tiyptic-soy agar containing 10% sheep blood for 48 h in a 
microaerobic environment. A loopfiill o f  each strain were removed from the plate and the 
DNA extracted as previously described (25). PCR conditions were as stated above except 
50 ng o f genomic DNA was used in the reaction with p-3F and p-6R for 35 cycles at an 
annealing temperature o f  55°C. The PCR reactions were then mixed with 6X sample 
buffer and 20 pl o f  each were electrophoresed on a 1% agarose gel in TAE buffer and 
stained with ethidium bromide. Each strain was also screened for phenotypic expression 
of a cytotoxin in a biphasic system using 12-well plates (Costar). A loopfiill of each strain 
was inoculated into 2 ml o f minimal essential media (MEM) without fetal bovine serum 
(FBS) and used to overlay 1 ml of Meuller-Hinton agar present in the bottom of the wells. 
The organisms were grown for 48 h at which time the liquid medium was removed and 
centrifuged to remove the bacteria. HEp-2 cells were subcultured into 96 well plates at a 
density of 1 X 104 cells/well with 200 pl MEM supplemented with 10 % FBS 24 h prior to 
the addition o f the toxic filtrate. The supernatant fluid was assayed for cytotoxic activity 
by replacing the 200 pl o f growth medium used in subculturing the Hep-2 cells with 200 
pl of the organism free filtrate. The cells were monitored over a 48 h period for 
cytological changes. E. coli 0157:H7 strain 3787 (H19), positive for verotoxin type 1 
(VT1), and strain 90-2380, positive for verotoxin type 2 (VT2), were used as positive 
controls for the cell culture assay while uninoculated medium was used as the negative 
control.
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Table 3.2.
Screening o f 23 strains o f C. jejuni and 9 strains of related organisms for 
phenotypic expression o f a cytotoxin and presence of porA using primers specific for the 









C. jejuni 3454 human 4 la + +
3969 NA untypabie I + +
4951 human 7 I + +
4966 human 7 I + +
6847 human 1 la + +
7099 chicken 61 + +
7288 water 9 II + +
8916 human 94 Ila + -r
9214 human 2 la + +
9541 water 82 II + +
9543 water 82 II + +
9555 human 23 I + +
10403 human 36 la + -
10673 human 82 II + +
14040 human 82 II + +
14906 human 82 I + +
15151 human 82 I + +
16323 beef 82 I + +
16334 human 82 II + +
16336 human 82 II + +
16388 (2483) human 82 II + -r
1 NA 4 I + +
2074 NA 36 II + -
C. lari 729 NA 31 I + -
C. coli 348 NA 14 I + -
C. sputorum subsp. fecalis 5754 NA NT NT + -
C. fe tu s  subsp. fe tu s 7055 NA NT NT + -
C. hyointestinalis 8494 human NT NT + -
C. jejun i subsp. doylei 9365 NA NT NT + -
A . butzleri 13220 human 7 iiia + -
E. coli VT1+ 3787(19) NA NT NT + -
E. coli VT2+ H19 human NT NT + -
NT not tested
NA information not available
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3.3.6 Genbank accession number. Genbank U96452
3.4 Results
3.4.1 Vectorette PCR.
Vectorette PCR was performed using the genomic DNA digested with Nhe I 
ligated to its corresponding common oligonucleotide which generated amplicons suitable 
for DNA sequencing. The universal primer (UVP) and p-lF, p-2F and p-3F yielded 
amplicons of similar size of approximately 800 bp in length which was consistent with the 
position of the Nhe I restriction site (Fig 3.3) and the position of the primers (Table 3.1). 
DNA sequencing of the three amplicons revealed the same sequence which, when 
translated, contained an ORF corresponding to' the protein sequence obtained from the N- 
terminus of the cytotoxin (26). No other amplicons were seen with the remaining genomic 
digests when the PCR conditions were maintained. From the DNA sequence, primer p-6R 
was designed from nucleic acid positions 768 to 749 of the sequenced amplicon. This new 
primer was used in a PCR reaction with primer p-3F to amplify a 650 bp amplicon. The 
amplicon was used as a DNA probe on a Southern blot to localize the cytotoxic porin 
gene.
3.4.2 Partial cloning and sequencing of cytotoxic porin protein.
Southern blot analysis of the digested genomic DNA using the digoxigenin-labeled 
cytotoxic porin probe yielded several discrete bands when probed with the 650 BP probe 
(Fig 3.4). The Spe I fragment was chosen, purified and ligated to pUC 19 and used to 
transform Epicurian coli XL 1-blue competent cells. One colony from the Spe I digested
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Figure 3.3.
Schematic diagram o f the sequencing reactions and restriction map ofporA from 
C. jejuni strain 2483 showing the restriction sites for the enzymes used in the generation 
of the vectorette library. The arrows designate the direction and primer used in the 
sequencing o f the intact gene.
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Figure 3.4.
Southern blot analysis o f  genomic digests using a digoxigenin-labeled 650 bp 
probe. Lanes 1 and 10: Hind IQ digested lambda DNA; Lane 2: Hind HI digested C. 
jejuni genomic DNA; Lane 3: Bam HI digested C. jejuni genomic DNA; Lane 4: Bgl I 
digested C. jejuni genomic DNA; Lane 5: Nhe I digested C. jejuni genomic DNA; Lane 
6: EcoRl digested C. jejuni genomic DNA; 7: Bel I digested C. jejuni genomic DNA; 
Lane 8: Spe I digested C. jejuni genomic DNA; Lane 9: E. coli Xba I digested genomic 
DNA
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and extracted genomic DNA, which was positive by PCR for the 650 bp product was 
designated Cj08 and this was sequenced. Inverse PCR was only performed on Hind III 
digested DNA because o f the results obtained from the Southern blot analysis using the 
650 bp probe and the restriction map (Fig 3.4) o f  the amplicon initially generated from the 
Nhe I vectorette library. The Southern blot showed a weak reaction between the 
digoxigenin-labeled probe and an approximate 800 bp fragment making  it a potential 
candidate for amplification by inverse PCR. A new primer, p-7R, which was generated 
from positions 5’-209-> 190-3’ of the sequenced amplicon from the vectorette PCR, 
together with p-3F produced an 800 bp product with the ligated Hind IQ digested 
genomic DNA. When sequenced the amplicon was found to contain the N-terminus o f the 
porin protein along with the entire leader sequence with the start codon and the ribosome 
binding site. The sequence data and translated protein obtained from the clone and the 
inverse PCR are shown in Fig 3.5. The restriction map revealed a Spe I restriction site at 
position 6 o f  the functional gene therefore the Spe I clone only contained part of the 
functional gene but the remainder o f the gene was elucidated from the sequence the 
amplicon generated from the inverse PCR reaction.
The entire gene was found to be 1275 bp in length and was designated porA. The 
protein encoded was 424 amino acids in length (Fig 3.5) and had a calculated molecular 
weight o f 45.6 kDa and a pi o f 4.44. The leader sequence was found to be 22 amino acid 
residues in length and was cleaved from the active protein conforming to the -3,-1 rule 
(12) between the Ala->22 (A) and Thr—>23 (T), which was the first amino acid residue in 
the sequenced protein (26, section 2.4.2). The mature protein, minus the leader sequence 
has a calculated molecular weight o f 43.5 kDa and had a pi o f  4.35. These findings were
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RBS M K L V K
AACTTAGTTTAGTTGCAGCTCTTGCTGCAGGTGCTTTTTCAGCAGCTAACGCTACTCCAC
L S L V A A L A A G A F S A A N A T P L
TTGAAGAAGCTATCAAAGATGTTGATGTATCAGGTGTATTAAGATACAGATACGATACAG 
E E A I  K D V D V S G V L R Y R Y D T G
GTAATTTTGATAAAAATTTCGTTAACAACTCAAATTTAAACAACAACAAACAAGATCACA
N F D K N F V N N S N L N N N K Q D H K
AATATAGAGCACAAGTTAACTTCAGTGCTGCTATAGCTGATAACTTCAAAGCTTTCATTC
Y R A Q V N F S A A I A D N F K A F I Q
AGTTTGACTACAACGCTGTTGATGGTGGCACTGGTGTTGATAACGTAACAAATGCCGAAA
F D Y N A V D G G T G V D N V T N A E K
AAGGACTTTTTGTTCGTCAATTATACTTAACTTATACAAATGAAGATGTTGCTACAAGTG
G L F V R Q L Y L T Y T N E D V A T S V
TAATCGCTGGTAAACAACAATTAAACCTTATCTGGACGGATAACGCTATTGATGGTTTAG
I A G K Q Q L N L I W T D N A I D G L V
TAGGAACAGGTATCAAAGTAGTAAACAACAGCATCGATGGTTTAACTCTAGCTGCTTTTG 
G T G I  K V V N N S  I D G L T L A A F A
CTGTAGATAGCTTTATGGCGGAAGAGCAAGGTGCAGATTTATTAGGACAAAGTACTATAT













6 6 1  CTACAACACAGAAAGCAGCTCCTTTTAAAGTGGATTCAGTAGGAAATCTTTATGGTGCTG 7 2 0
T T Q K A A P F K V D S V G N L Y G A A  2 0 5
7 2 1  CTGCTGTAGGTTCTTATGATCTTGCTGGCGGACAATTTAATCCACAATTATGGTTAGCTT 7 8 0
A V G S Y D L A G G Q F N P Q L W L A Y  2 2 5
7 8 1  ACTGGGATCAAGTAGCATTCTTCTATGCTGTAGATGCAGCTTATAGTACAACTATCTTTG 8 4 0
W D Q V A F F Y A V D A A Y S T T I F D  2 4 5
8 4 1  ATGGAATCAACTGGACACTTGAAGGTGCTTACTTAGGAAATAGCCTTGATAGCGAACTTG 9 0 0
G I N W T L E G A Y L G N S L D S E L D  2 6 5
9 0 1  ATGATAAAACACACGCTAATGGCAATTTATTTGCTTTAAAAGGTAGCATTGAAGTAAATG 9 6 0
D K T H A N G N L F A L K G S I E V N G  2 8 5
9 6 1  GTTGGGATGCTAGCCTTGGTGGTTTATACTACGGTGATAAAGAAAAAGCTTCTACAGTCG 1 0 2 0
W D A S L G G L Y Y G D K E K A S T V V  3 0 5
1 0 2 1  TAATCGAAGATCAAGGTAATCTTGGTTCTTTACTTGCAGGTGAGGAAATTTTCTATACTA 1 0 8 0
I E D Q G N L G S L L A G E E I  F Y T T  3 2 5
1 0 8 1  CTGGTTCAAGACTAAATGGTGATACTGGTAGAAATATCTTCGGTTATGTAACTGGTGGAT 1 1 4  0
G S R L N G D T G R N I  F G Y V T G G Y  3 4 5
1 1 4 1  ATACTTTCAACGAAACAGTTCGCGTTGGTGCTGACTTCGTATATGGTGGAACAAAAACAG 1 2 0 0
T F N E T V R V G A D F V Y G G T K T E  3 6 5
1 2 0 1  AAGATACTGCTCATGTAGGTGGTGGTAAAAAACTTGAAGCTGTTGCAAGAGTAGATTACA 1 2 6 0
D T A H V G G G K K L E A V A R V D Y K  3 8 5
1 2 6 1  AATACTCTCCAAAACTTAACTTCTCAGCATTCTATTCTTATGTGAACCTAGATCAAGGTG 1 3 2 0












1 3 2 1  TAAACACTAATGAAAGTGCTGATCATAGCACTGTAAGACTTCAAGCTCTTTACAAATTCT 1 3 8 0  
N T N E S A D H S T V R L Q A L Y K F *  4 2 4
1 3 8 1
1 4 4 1  TTTTAAAACT 1 4 5 0
1 4 4 0
Figure 3.5.
The nucleotide sequence ofporA from C. jejuni strain 2483. Single underlined sequence represents the 
putative Shine-Dalgamo ribosome binding site (RBS), -10 and -35 sequences and double lines represents a stem 
loop structure which may indicate a rho-independent transcription termination site with a 5 bp loop followed by a 
poly-T region o f DNA. Bold face letters represent initiation codon and represents termination codon and the 
numbering is for the nucleotide and amino acid count.
consistent with previous reports (26, 103, 118) regarding the size and pi o f the porin 
protein from C. jejuni. Primers, p-15F and p-16R were subsequently designed to PCR 
amplify the entire porin gene (Fig. 3.6) as well as for use in the sequencing reactions.
3 .43  Sequence analysis.
Sequence homology searches were performed on the entire ORF and translated 
protein using GCG (Genetics Computer Group, Madison, Wl). The translated porin 
protein from C. jejuni strain 2483 had no significant homology with any characterized 
protein except with the previously described C. jejuni porin protein (26) and the 45 kDa 
and 51 kDa outer membrane proteins form Wolinella recta (117). However, the DNA 
sequence had the greatest similarity with H. influenzae outer membrane protein P2 over 
short stretches following a BLAST search (BLAST; Beckman Center for Molecular and 
Genetic Medicine, Stanford University of Medicine) (Fig. 3.7). A comparative analysis of 
the translated porin from C. jejuni strain 2483 and several bacterial outer membrane 
proteins is shown in Fig 3.8. C. jejuni porin protein had a 50% sequence similarity but 
only 23% sequence identity with the H. influenzae major outer membrane protein P2. In 
addition, in those regions o f the DNA where the homology was greatest, the protein 
sequence identity was as much as 72%. The porin from C. jejuni also had a 46% 
similarity  and 21% identity with the Enterobacter cloacae pore forming outer membrane 
protein PhoE, 44% similarity and 21% identity with Klebsiella pneumoniae PhoE, 43% 
similarity and 17% identity with Salmonella typhi OmpC, and 42% similarity and 19% 
identity with E. coli PhoE. When the porin from C. jejuni was compared to the consensus 
sequence obtained from an alignment o f OmpF, OmpC, PhoE and Lc of E. coli, PhoE
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Figure 3.6.
PCR product generated from p- 15F and p- 16R which were used to amplify the 
entire porin gene. Lanes 1 and 3: 100 bp ladder (Gibco); lane 2: PCR amplified product..
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DNA sequence homology between H. influenzae outer membrane protein P2 and porA from C. jejuni strain 2483.
C. jejuni porA: 397
H, influenzae P2: 4 6 0
AACCTTATCTGGACGGATAACGCTATTGATGGTTTAGTA 4 3 5
I I II II I I I I I  l l l l l l l l l l l l
ACCGTTGGCTACACTTTTAAAGGTATCGATGGTTTAGTA 4 9 8
C. jejuni porA :
H. influenzae P2:
C. jejuni porA :
H. influenzae P2:
6 0 6  TGGTGCTGCTGCTGTAGGTTCTTATGATCTTGCTGGCGGACAATTTAATCCACAA 6 6 0
II l l l l l l l l l l l  I I I  I I I II II I I I  II II l l l l l l l l
5 5 5  TGCTGCTGCTGCTGCTGGTGGTGCTCGTGCTGTTGCAGGAGAAGTTTATCCACAA 609
7 5 2  TTGAAGGTGCTTACTTAGGAAATAG 7 7 6
II I I I I I I I II I M I I I I  I I I













C. jejuni PorA 
H. influenza P2 
E. cloacae PhoE 
K. pneumoniae PhoE 
S. typhi OmpC 
E. coli PhoE
C. jejuni PorA 
H. influenza P2 
E. cloacae PhoE 
K. pneumoniae PhoE 
S. typhi OmpC 
E. coli PhoE
C. jejuni PorA 
H. influenza P2 
E. cloacae PhoE 
K. pneumoniae PhoE 
S. typhi OmpC 
E. coli PhoE
C. jejuni PorA 
//. influenza P2 
E. cloacae PhoE 
K. pneumoniae PhoE 
S. typhi OmpC 
E. coli PhoE
1 5 0
M K lv k L s L v a a l a a g a f s A a n A t p l e e a i k d v D V s G v l r y r y d t g n f D k n
.m K k T L A a l l v G a f A a s a A n AAvVYNnEGt n v E l g G r l s i i a e q S n s t v d
MKKSTLALW M GvVAsAsvh AAEVYNKnGN KLDVYGKVKA MHYiSDdDtK
MKKSTLALmm M G f V A s t a t q AAEVYNKnaN KLDVYGKIKA MHYFSDyDSK
M K v k v L sL IV p a l l v a g a A n AAEIYNKDGN KLDlFGKVdg LH YFSD dkgs
MKKSTLALvV M G iV A sA svq AAEIYNKDGN KLDVYGKVKA MHYmSDnaSK
51 1 0 0
f v n n s n l n n n k Q d h k Y r a q v n f s a a l a D n F k a F i q F D y n a v d g g T g v D n v
n q k Q q h g a l r n Q g s R F . . h i K a t h n f g D g F y a q G y L E t r F v t k a s E n g S d
DGDQTYV. . . ____ R F . . G f KGETQINDQL TGYGRWEaEF aG N K aESD S.
DGDQTYV. . . ____ R F . . G i KGETQINEdL TGYGRWEsEF sGNKTESDS.
DGDQTYm. . . ____ R i . . G f KGETQVNDQL TGYGqWEyqi qG N q T E . g S .
D G D Q sY I. . . ____ R F . . G f KGETQINDQL TGYGRWEaEF a G N K a E S D t .
1 0 1 1 5 0
t n a E k g l f v r q l y l t y T n e d v A t s v i a g k q q L n l i W t d n A i d g l v g t g i k
n f g D i t . . . . ...............s k y A Y v tL g n K a F G e v k l G R a k t i a d g l t s a e D .
. . s . Q K ------- ...............TRLA FAGLKLKDFG SLDYGRNLGA LYDVEAWTDM
. . sqQK ...............TRLA FAGvKLKnYG SFDYGRNLGA LYDVEAWTDM
. . n D s w . . . . ...............TRvA FAGLKFaDaG SFDYGRNyGv tY DVtsW TDv
. . a q Q K ------- ...............TRLA FAGLKYKDLG SFDYGRNLGA LYDVEAWTDM
151 2 0 0
w n n s i d g l t L a a F a v D S f m a e e Q g a d L L g q s t i s t t q k A a p F k v d s v g n
. k E Y G v . . . . . . I n n s d Y i p t s g n t v . . . g y T F k . . . g i D
FPEFGGD SS. . . AQTDNFMT KRASGL. . .  A . TY R . . . NTD
FPEFGG DSS. . .AQTDNFMT K R A S G L .. .A . T Y R . . .NTD
L P E F G G D ty . . , g . aDNFMq q R g n G y . . .A . T Y R . . .NTD













C. jejuni PorA 
H. influenza P2 
E. cloacae PhoE 
K. pneumoniae PhoE 
S. typhi OmpC 
E. coli PhoE
C. jejuni PorA 
H. influenza P2 
E. cloacae PhoE 
K. pneumoniae PhoE 
S. typhi OmpC 
E. coli PhoE
C. jejuni PorA 
H. influenza P2 
E. cloacae PhoE 
K. pneumoniae PhoE 
S. typhi OmpC 
E. coli PhoE
C. jejuni PorA 
//. influenza P2 
E. cloacae PhoE 
K. pneumoniae PhoE 
S. typhi OmpC 
E. coli PhoE
2 0 1 2 5 0
L Y G a a a v g s y d L a g g q f N p q l w l a y w D q v a f f y a v d a a Y s T t i . . . F d G i
g L v L g a n y l L a q k r e G a k G e n k r p N d k a g E v r i g e i n n . G i q v g a k Y d a n
FFGalDGLDM TLQYQGKN ...............EnRD aKKQNGDGFG TSLTYDFGGT
FFGLVDGLDL TLQYQGKN , aKKQNGDGvG TSLsYDFGGT
FFGLVDGLDF aLQYQGKNGs v s g e N t n g R s llnQNGDGYG g S L T Y a l G e .
FFG vID G LnL TLQYQGKN ...............EnRD vKKQNGDGFG TSLTYDFGGs
2 5 1 3 0 0
n W t le G A Y lg n s l d s e l d D k T h a n g n L f a l k g s i e v n g w D A s lg G L y Y g d
D i v a k i A Y , .....................gR T N y k y n e a d e h k q q l n g v l a t l g y r F s d l g
DFAVSGAYTN S ..................DR TNaQNILARA . . . .QGqkAE AWATGLKYDA
DFAVSaAYTs S ..................DR TNDQN1LARA . . . .QG skAE AWATGLKYDA
g F s V g G A iT t S ..................kR TaD Q N ntA nA r l y g n G d r A t vYtgGLKYDA
DFAISGAYTN S ..................DR T N E Q N lq sR g ____ tG k r A E AWATGLKYDA
3 0 1 3 5 0
k e k a s t w i e D q g N L g s l l a g e e i f y t T g s r L n g d t g r n i f g y V t g g Y t F
H V s L d s g Y a kT k N y k . . .V sp g F Q Y
NdlYLAaMYS ETRNMTPISG GFANKAQNFE . . . WAQYQF
NNIYLAtMYS ETRkMTPISG GFANKAQNFE . . . aVAQYQF
NNIYLAaqYS q T y N a T r f g t s n g s n p s T s y GFANKAQNFE . . .W AQYQF
N N IY L A tfY S E T R kM TPItG GFANKtQNFE . . . aVAQYQF
3 5 1 4 0 0
n e t v R v g a d F V y g g t K t e d t a h v g . . G g k k L e a v a r V d y k Y s p k lN F S A F
E L .M e d tn v Y g n f K y e r t S v d q G E k t r E q a v l . . . . f G v d h k L h K q L l t Y
DFGLRPSLGY VqSKGKDn. . . . . EGIGDED LVkYIDVGAT YYFNKNMSAF
DFGLRPSLGY V 1SK G K D I. . . . . EGVGsED LVnYIDVGIT YYFNKNMnAF
DFGLRPSvaY lqS K G K D IS n gyG asyG D qD iVkYVDVGAT YYFNKNMStY













4 0 1 4 3 4
C jejun i PdrA y s Y . . . . v n l D q g v n t n e s a  D h s t V r l q a l YkF*
H. influenza P2 I E g a y a r t r t t e t g k g v k t e k E k s V g v G L r v y F *
E. cloacae PhoE VDYKINQiDd D N . . . KLGVs sDDIVAvGMT YQF*
K. pneumoniae PhoE VDYKINQLkS D N . . . KLGIN DDDIVA1GMT YQF*
S. typhi OmpC VDYKINlLDk ndftrdaGIN tDDIVAlGLv YQF*
E. coli PhoE VDYKINQLDS D N . . . K LnIN nDDIVAvGMT YQF*
Figure 3.8.
Alignment o f C. jejuni PorA with H. influenza P2, E. cloacae PhoE, K. pneumoniae PhoE, S. 
typhi OmpC, and E. coli PhoE using GCG (Genetics Computer group). Capital letter represent identical 
or conserved changes, small letters represent mismatches in the sequences and spaces (...) were inserted 
in order to achieve the best alignment. represents termination codon.
of K. pneumoniae and ompC of S. typhi (176) a 45% similarity and 20% identity was 
found (Fig. 3.9).
3.4.4 Screening Campylobacter sp. for porA and  cytotoxin production.
Results o f  screening C. jejuni for phenotypic and genotypic expression of the 
cytotoxin gene are summarized in Table 3.2 (pg 85). It was found that all 32 strains of 
Campylobacter sp. and related organisms produced a cytotoxic component when the 
filtrate from the biphasic growth system was assayed in tissue culture but only 21 of 32 
(66%) were PCR positive using the primers (p-3F and p-6R) specific for porA. However, 
21 o f 23 (91%) o f  the C. jejuni strains screened for porA were PCR positive for the 650 
bp product showing that the porin gene was highly conserved among strains of C. jejuni, 
especially Lior serotype 82, but was not conserved between related species of 
Campylobacter. The two strains o f C. jejuni which were PCR negative for the porA gene 
belonged to Lior serotype 36. More work is needed to determine if  the negative PCR 
result is conserved among strains within this group.
3.4 Discussion
The major outer membrane protein (MOMP) o f C. jejuni was first isolated and 
reconstituted into lipid bilayer membranes and found to form small channels consistent 
with that o f a porin (103). The MOMP has an apparent molecular weight o f 45 kDa 
under native conditions and since 3-folded monomers are needed to form the functional 
porin, it was confirmed to be part o f the trimeric porin family (26). The N-terminal 
sequence has been elucidated and been found to contain little homology with other 
bacterial porin proteins (26) but it did share homology with two outer membrane proteins
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C. j e j u n i  PorA 
consensus 
C. j e j u n i  PorA 
consensus 
C. j e j u n i  PorA 
consensus 
C. j e j u n i  PorA 
consensusVO
VO
C. j e j u n i  PorA 
consensus 
C. j e j u n i  PorA 
consensus 
C. j e j u n i  PorA 
consensus
1 MKLVKLSLVAALAAGAFSAANATPLEEAIKDVDVSGVLRYRYDTGNFDKN
I • I • I •*  • • • • • • • ! •    •
1 ..........................................................AEIYNKDGNKLDLYGKV............................... D
5 1  FVNNSNLNNNKODHKYRAOVNFSAA . . IADNFKA F IO F DY NAVDGG
: : . | | | |  | : | : : J T • 5 -
19  GLHYFSDNDSKDGDOTYARFGFKGETOIDNOLTGYGOWEYEFOGNKAESD 
95  TGVDNVTNAE KGL FVROLYLTYTN E DVATSVIAGKOOLNLIWTDNAIDGL
h I II h.=..............: : : • =1 • = :
6 9  TSOOKTRLAFAGLKFKD............................. TGS FDYGRNYGWYDVEAWTDM
1 4 5  V GTGIK W NN SI DGLTLAAFAVDSFMAEEOGADLLGOSTISTTOKAAPFK
. .  | . | . | |  | | : 
1 0 8  L P ............................. EFGGDSSATDNFM..............................................T KRASGLA
1 9 5  VDSVGNLYGAAAVGSYDL. . AGGOFNPOLWLAYWDOVAFFYAVDAAYSTT 
. . • : : : | . . .  . |  - | . : « .  . | .
1 3 1  TYRNTDFFGLVDGLNFAVOYOGKNENRDVKKONGD................GVGGSLTYD
24 3 IFDGINWTLEGAYLGNSLDSELDDKTHANGNLFALKGSIEVNGWDASLGG 
: : :  : : . : : | | |  . |  | . .  | : .  : | . | |  . .  : | .  . |  
1 7 5  FEGSSDFGIGGAY. . TSSDRTNDONLOARGN.........................GKRAEAWATG
2 9 3  LYYGDKEKAST W I E D OGNLGSLLAGEEIF Y T TGSRLNGDTGRNIFGYVT 
| | : • • : : |  | . . .  . : : :




























C . j e j u n i  PorA 3 4 3  GGYTFMnVRySADF2Q[GGTKTj^TAHVGGGKKIiEAVARVDYKYSPKLNF 3 9 2
: . | | | . : . : : : . | : | | : . . | . | : . | . | : 
consensus 251 aoyofdfglrpslayloskgkdie ggdedlvkyvdvgatyyfnknm 296
C . j e j u n i  PorA 393  s a f y s y .v n l d o g v n t .n e s a d h s t v r l o a l y k f* 4 2 5
consensus 297  s t f v d y k i n l l d s d n k l g i n t d d i v a a l g l v y o f. 330
Figure 3.9.
Comparative analysis o f the enterobacterial consensus sequence with the C. jejuni translated PorA. 
Vertical line represent identical residues, colons represent changes with a comparison value ^  0.5; represent 
residues with a comparison value £ 0.1. Gaps were inserted in order to obtain the best fit. Underlining in the 
enterobacterial consensus sequence represent hypothetical membrane spanning regions as determined by the method of 
Chou-Fasman (176), while double lines represent stretches o f extended conformation in PorA as determined by the 
method o f Gamier (78). represents termination codon.
from W. recta (117). In this thesis it was reported that the porin-LPS complex from C. 
jejuni possessed a heat-labile cytotoxic activity (section 2.4.1)
This is the first study to  provide information regarding the complete genetic 
sequence and the translated porin protein from C. jejuni. The 1275 bp ORF had a % mol 
guanosine+cytosine content o f  36.8 mol % (Fig. 3.5) which is slightly higher than the 
range previously described for C. jejuni chromosomal DNA (244, 246). A putative Shine- 
Dalgamo (SD) sequence which has previously been described (199) with a sequence o f 5’- 
AGGAG-3’, lies centered 10 bp upstream from the initiation codon ATG. A putative -35 
region, which has been previously described (199) is centered 87 bp upstream from the 
initiation codon with a sequence o f 5’-TTTACT-3’ while a putative -10 region, 5’- 
TTAAGA-3’ is centered 57 bp upstream (Fig 3.5). Both the -35 and -10 sequences were 
predicted as putative sites using PC/Gene software package (Intelligenetics, Inc.) and 
comparative analysis with putative sites from published sequences from C. jejuni. A 
potential termination sequence was present 25 bp down stream from the stop codon 5’- 
TAA-3’ (Fig 3.10). It consisted o f a 9 bp dyad stem loop with a predicted stability of -
19.2 kcal/mol separated by 5 impaired bases which could comprise the loop structure.
This is followed by a poly-T region and could signify a rho-independent termination 
sequence (4).
With very few exceptions, codon usage in the coding region of porA gene were 
consistent with the compilation available through Genbank (Table 3.3). For instance, Tyr 
was equally encoded by UAU and UAC while GUA was used more frequently to encode 
Val rather than GUU and AUC encoded lie instead of AUU. The most striking difference 
was the number o f Phe encoded by UUC which had previously been shown to be encoded
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G : C 
A:T
1410 - G:C - 1420 
G : C 
C : G 
G : C 
G: C





Stem loop structure o f the termination sequence. Numbering represents the 
position of the loop in the 1450 bp fragment containing the ORF of the porA gene from 
Fig 3.5.
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Table 3.3.
Codon usage chart for the 1275 bp open reading frame porA from C. jejuni 
strain 2483.
UAA - He AUC 9 Arg CGU 1
UAG - AUA 2 AGA 7
UGA - AUU 4 CGC 1
Ala GCU 35 Lys AAA 22 CGA 0
GCC 1 AAG 0 AGG 0
GCG 1 Leu CUU 17 CGG 0
GCA 11 CUA 4 Ser UCA 6
Cys UGU 0 CUG 0 UCC 0
UGC 0 UUG 0 UCG 0
Asp GAU 30 UUA 17 UCU 6
GAC 2 c u e 0 AGC 7
Ghi GAG 2 Met AUG 2 AGU 6
GAA 15 Asn AAC 19 Thr ACG 1
Phe UUU 10 AAU 15 ACC 0
Gly GGC 3 Pro CCC 0 ACU 14
GGA 9 e c u 1 ACA 14
GGG 0 CCA 3 Val GUC 1
GGU 32 CCG 0 GUG 2
His CAC 2 Gin CAG 2 GUU 12
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more frequently by UUU while AAC rather than AAU encoded Asn. These frequencies 
were most likely due to the quantity of % mol G+C residues in the coding region and 
these may confer an increase in gene stability at increased temperatures especially as the 
organism is considered to be thermophilic.
The ORF was found to produce a 45.6 kDa protein with a p i o f 4.44, both of 
which are consistent with previous reports on the C. jejuni porin protein (26, 103, 118). 
The translated protein was also found to contain several hydrophobic regions as 
determined by the method ofNovotny and Auflray (179) (PC/Gene) (Fig. 3.11).
Structural prediction using the method of Gamier (78) (Fig. 3.9) (PC/Gene) and Novotny 
(179) (Fig 3.11) indicated there was also considerable secondary structure associated with 
the porin with 50% o f the amino acids forming extended or P-pleated sheet 
conformations. This was consistent with previous circular dichroism (CD) findings (26) as 
well as with other bacterial porin proteins from Rhodobacter capsulatus, E.coli and E. 
cloacae (176). The number of residues necessary to span the membrane has been 
estimated from 7?. capsulatus porin to be between 6 to 17 residues in length (205). Based 
on this assumption, together with the P-pleated sheet diagram and hydrophobic chart (Fig 
3.11), there may be as many as 12-membrane spanning domains while R. capsulatus 
contains 8 P-strands (176). The number of membrane spanning regions was predicted by 
the method o f Novotony using PC/Gene software package. The program determines the 
propensity o f a given residue to exist in a certain structure by examining the charge profile 
o f each amino add  in the primary structure.
The relative amount of sequence identity was low compared to the sequence 
similarity. This indicated that, although the primary structure was quite distinct, the
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A. PorA from C. jejuni strain 2483
Beta
Hydro
80 160 2 4 01 320 4 0 0
B. H. influenzae P2
Beta
M FI




1 70 140 2 1 0  2 8 0  350
C. C. jejuni FlaA
Bela
Hydro
200100 300 400 500
Figure 3.11.
Hydrophobic profiles and beta sheet propensities as determined by the method o f 
Novotny (179) using PC/Gene software package. A) C. jejuni strain 2483 PorA; B) H. 
influenzae P2; C) C. jejuni FlaA (87).
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properties associated with the 424 amino acid protein were similar to those of other well- 
characterized porins (Fig 3.8). For instance, the relative amounts of basic, polar and 
acidic residues are similar to that oiH. influenzae P2 as well as the enterobacterial 
consensus sequence; however, there was a greater frequency of hydrophobic residues in 
the porin from C. jejuni (Table 3.4). This could coincide with more membrane spanning 
regions leading to a more extensive secondary structure. When the C. jejuni porin 
sequence was compared to the hypothetical folding pattern o f the enterobacterial 
consensus sequence (Fig 3.11), there was no more significant similarities in the membrane 
spanning regions o f  the consensus sequence than in the remaining  sections. Comparison 
o f the N-terminal sequences of H. pylori porin proteins (56, 64) showed very little 
sequence identity with the porin from C. jejuni (Fig. 3.12) However, when the sequences 
were compared for similarities, the porin from C. jejuni had the greatest similarity with 
HopC (57%) followed by HopE (55%) then HopD and HopB (50%) and the least 
similarity with HopA (47%) (Fig. 3.12). TTie conductance levels of the channels formed 
by the H. pylori porin range from 0.25 to 0.36 nS (64) which is considerably lower than 
the conductance o f  8.82 nS reported for the C. jejuni porin (103). The molecular weights 
o f each o f the H. pylori porins are greater than the porin from C. jejuni and also appear to 
present as monomers in lipid bilayers (64) instead of the trimeric form similar to C. jejuni 
porin (26).
The MOMP has been found to elicit an immune response both in humans (178) 
and rabbits (65) making it a suitable candidate for vaccine development. PCR studies to 
determine the frequency o f the porin gene in other strains o f C. jejuni showed that 95% of
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Table 3.4.
Comparison o f the amino acid composition o f PorA from C. jejuni strain 2483, H. 
influenzae P2 and the consensus sequence from enterobacterial porin. Numbers in 
parentheses represent residues in the leader sequence.



























































































a data derived from Hansen et al. (64) 
bData dervied fromH. Nikaido (176)
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C. jejuni PoiA 
H. pylori Hop A
336 NIFGYVTGGYTFNETVR 352
1 NDGVFMSVGYQIGQAVQ 17




C. jejuni PorA 
H. pylori HopC
157 DGLTLAAFAVDS FMAEEQGAD 177
• I *  • • • • | • I • ••  I •  • • • • • •  •  I •  « l i t *
3 GGFFTVGYQLGQVMQDVQNPG 23
C. jejuni PorA 89 NAVDGGTGVDNVTNAE KG 106
H. pylori HopD 2 NGPEVAAGYQDGESAQMV 19
C. jejuni PorA 2 4 0  STTIFDGINWTLEGAYLGNSLDSELDDKTHANG 2 7 2
: : : I • I : I : • I • I : I : : : • -I
H. pylori HopE 2 GDGVYIGTNYQLGQA. . . . RLNSNIYNTGDXTG 30
Figure 3.12.
Significant sequence homology of the C. jejuni, strain 2483, cytotoxic Pro A and 
the Helicobacter pylori porin family proteins using best fit (Genetics Computer Group 
software package). Vertical lines represent identical residues; colons represent changes 
with a comparison value £ 0.5; represent residues with a comparison value ^0.1; “X” 
represents unknown residue. Numbering designate the location of the respective sequence 
within the alignments
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these contained at least part, if  not all o f  the intact gene while the other Campylobacter sp. 
and related organism were PCR negative. Previous reports indicated that only 60% of 
pathogenic strains possessed a protein o f similar size as determined by SDS-PAGE and 
Western blot analysis using antiserum against the MOMP from C. jejuni strain 85H (118). 
The PCR results outlined above are intriguing, and may provide a new and efficient 
method to differentiate C. jejuni from other Campylobacter sp. However, considerable 
testing, including sequencing o f porin genes from related species of Campylobacter is 
required to  identify regions of the genes which are unique to a given species. The 
potential for the development of a recombinant vaccine using the porin protein is also 
noteworthy. Previous studies by Gonzales et al. (90) have shown that T-cell activation 
occurred through the induction oflymphokines by S. typhi porin which may lead to 
protective immune response. Protection in guinea pigs was seen by using the 
enterobacterial outer membrane protein PhoE as a vector to express B-cell epitopes on the 
surface oiE . coli providing a vehicle for live vaccine development (250).
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Section IV
Preliminary effects of cytotoxic porin protein from 
Campylobacter jejuni on host cell processes
4.1 A bstract
Campylobacter jejuni is recognized as one o f the major causes of bacterial- 
induced gastroenteritis in developed and developing countries. C. jejuni possesses many 
pathogenic mechanisms for inducing disease which include binding to and intracellular 
replication within host cells as well as the production of different toxic products. Among 
those described are: 1) lipopolysaccharide (LPS) 2) hemolysin; 3) a much disputed 
enterotoxin; 4) a cytolethal distending toxin (CLDT) and 5) a cytotoxin. Previous 
sections outlined the purification and characterization of a 45 kDa cytotoxic protein and a 
co-purifying carbohydrate moiety. Preliminary studies were conducted in order to define 
the mode o f action o f the cytotoxin by evaluating the effects of cytotoxic filtrate on cyclic 
GMP levels and host cell protein synthesis. Levels o f cGMP were measured by 
radioimmuno assay in INT-407 cells following intoxication with cytotoxic filtrate. Control 
cells were found to contain 2.63 XIO'20 mol cGMP/cell while duplicate cells contained 2.7 
XIO'20 mol cGMP/cell after being intoxicated for 24 h. The cytotoxin does not effect 
cGMP levels in affected cells. The effects of cytotoxic filtrate on protein synthesis in ENT- 
407 cells were measured by assaying for incorporation of L-[3H]-leucine
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following intoxication. Intoxicated cells showed an 84% decrease in cellular protein 
synthesis as compared to control cells. Purified cytotoxin was also found to induce DNA 
fragmentation as early as 24 h post-intoxication in HEp-2 cells but not in Vero cells after 
48 h  o f  intoxication. This could signify that the intoxicated cells are becoming apoptotic.
4.2 Introduction
Enteric pathogens colonize the intestinal tract and invade the tissue lining of the 
lumen by a number o f different m echanism s leading to intracellular replication (257).
Many produce potent exotoxin(s) leading to  cell death and/or ion imbalance (138, 225, 
257). C. jejuni has been shown to adhere to  the epithelial cells lining the lumen of the 
intestine via flagella, LPS and membrane proteins leading to the invasion o f the underlying 
follicles (92, 119). In addition, C. jejuni has been shown to produce an enterotoxin similar 
to that o f  Vibrio cholerae (47, 53,108), as well as a cytolethal distending toxin (109, 202) 
and a potent cytotoxin (85, 150, 151). However, the role that C. jejuni exotoxin’s play in 
pathogenesis has not been elucidated.
Bacterial exotoxins can effect host cells processes a variety of different ways (94, 
138). A  family of bacterial exotoxins, commonly referred to as bAREs (bacterial ADP- 
ribosylating exotoxins) modify proteins involved in crucial host cell functions leading to 
cell death or ion imbalance (138). These particular exotoxins are commonly subunit 
proteins consisting o f an A:B structure (138) and act by covalently transferring the ADP- 
ribose moiety o f NAD+ to specific eukaryotic target proteins leading to either activation 
per se or to inactivation of the target protein (138). The enterotoxin produced by V. 
cholerae (CT) and the heat-labile enterotoxin produced by E. coli (LT) are multimeric
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bAREs consisting o f  1 A-subunit surrounded by 5 B-subunits (225). The B-subunits are 
involved in the binding o f the toxin to gangloside GMt present on the surface o f the 
epithelial cells lining the lumen of the intestine while the active A-subunit is translocated 
into the cytoplasm o f  the cell (138,225).
Both CT and LT act by ADP-ribosylating the GTP binding proteins present in the 
intestinal epithelial cells leading to an increase o f intracellular cAMP. The increase of 
intracellular cAMP stimulates the release o f ions and fluid into the lumen of the intestine 
from the intoxicated cells with the end result being severe, watery diarrhea (138, 225). 
Both enterotoxins have been cloned and sequenced and the genes for the A-and B- 
subunits were found adjacent to one another in the same operon. In order to maintain the 
5:1 ratio o f B:A-subunits, the ribosome binding site for the B-subunit was found to 
promote translation at a higher rate than the ribosome binding site associated with the A- 
subunit (21).
Escherichia coli also produces two distinct heat-stable enterotoxins (ST1 and 
STH) (51, 97). STI is a short, acidic peptide consisting of 18-19 amino-acids which cause 
an increase in intracellular cGMP levels leading to fluid accumulation in the lumen of the 
intestine, in much the same manner as the heat-labile enterotoxin (51, 224, 266). STII 
comprises 48 amino-acids and acts by stimulating increased level o f prostaglandin E2 in the 
lumen of the intestine. The effect of this build up is to induce secretion of water and 
electrolytes into the lumen leading to watery diarrhea (97). Certain strains of C. jejuni 
have been shown to increase leukotriene B4, prostaglandin E2, and cAMP levels in rabbit
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ileal loops leading to fluid accumulation (62). These findings suggest the production by C. 
jejuni o f  an enterotoxin similar to those produced by E. coli and V. cholerae (47, 53).
Another group of bAREs act by transferring the ADP-ribose moiety o f NAD+ to 
elongation factor-2 (EF-2) thereby inhibiting eukaryotic protein synthesis (46, 138). 
Diphtheria toxin (DT), produced by Corynebacterium diphtheriae, and exotoxin A (ETA) 
produced by Pseudomonas aeruginosa, are two examples o f cytotoxins which act in this 
fashion (138). Both have been cloned and sequenced but, unlike  the enterotoxins 
produced by E. coli and V. cholerae, they are single polypeptides with three domains: a 
recqptor binding domain, a translocation domain and a catalytic domain (46, 138). Other 
bAREs, which include several produced by Clostridium sp., ADP-ribosylate actin filament 
and prevent polymerization leading to destruction of the cell cytoskeleton (94, 138).
Other cytotoxins, which are not part o f the bARE family, have also been 
implicated in the inhibition o f protein synthesis (138). The potent toxins produced by 
Shigella dysenteriae and E. coli, most commonly referred to as Shiga-toxin and verotoxin 
respectively, are toxins which act by inactivating the 60S ribosome, effectively switching 
off protein synthesis (181,183, 211). They are multimeric proteins comprised of a 
catalytic A-subunit surrounded by 5 B-subunits which, like the B-subunit associated with 
the active enterotoxins, are responsible for binding to Gb3 present on host cell surface 
(181, 183). Cytotoxin-producing strains o f S. dysenteriae and E. coli have been 
implicated in dysentery, diarrhea, hemorrhagic colitus and the more serious condition, 
hemolytic-uremic syndrome (HUS) (181). Recently a strain o f Enterobacter cloacae has
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been implicated in a case o f  HUS and was shown to produce verotoxin similar to that of 
E. co //(192).
Some potent cytotoxins are not only capable o f producing dysentery in the host, 
but can induce apoptosis, or programmed cell death in intoxicated cells (45, 105). 
Apoptosis is characterized by DNA fragmentation, nuclear condensation and cytoplasmic 
blebbing (45, 105). Cytotoxins which interfere with protein synthesis, such as verotoxin 
(105) and diphtheria toxin (45) have been found to induce apoptosis. Pore-forming 
cytotoxins, such as Staphylococcus aureus a-toxin and E. coli hemolysin, induce 
apoptosis possibly by allowing an influx of Na+ (45). The influx o f Na+ has been shown to 
induce apoptosis since cells grown in medium without Na+ do not become apoptotic even 
though the toxin still induces holes in the cell membrane (45). A summary of toxins 
produced by C. jejuni and potentially related toxins together with their mode o f action and 
properties are shown in Table 4.1.
4.3 Material and Methods
4.3.1 Effects of C jejuni cytotoxin on cellular cyclic GMP levels.
Organism free filtrate from C. jejuni strain 2483, was obtained as previously 
described (section 2.3.1). Two T-75 cm2 flasks (Costar) containing INT-407 (ATCC, 
CCL-6) cells were grown to confluency in RPMI-1640 (Sigma) cell culture media 
supplemented with 10 % fetal bovine serum (FBS) (Sigma) at 37°C in 5% CO2. A total 
o f200 fig o f crude, concentrated organism-free filtrate from C. jejuni was added to one of 
the flasks and incubated for 24 h at 37°C. Following intoxication, the adherent and non­
adherent cells were collected and washed three times with Hank’s balanced salt solution 
(HBSS) to remove residual FBS and any cyclic nucleotides contained in the FBS. In order
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Table 4.1. List o f the some of the more common bacterial toxins along with properties and mode o f action.
Bacterium and toxin purified gene
cloned
Tvpe of Activitv/chanues induced in cells 
enterotoxic cytoskeletal cytotoxic mode of action Ref.
C. jejuni
enterotoxin partially - + + elevate cAMP (53)
CLDT crude Yes + + - (202)
cytotoxin crude - + - (166)
Aeromonas hydrophila
aerolysin purified Yes + + hemolytic (225)
Bordetella pertussis




Toxin A purified Yes + + secretory (94)
Toxin B purified Yes + + ADP-ribosylates actin (94)
Corynebacterium diphtheriae
diphtheria toxin (DT) purifed Yes + ADP-ribosylates EF-2 (46)
E. coli
heat-labile enterotoxin a & b purified Yes + elevate cAMP (225)
heat-stabile enterotoxin 1 &II purified Yes + elevate cGMP (51)
verotoxin I & II purified Yes + ADP-ribosylate EF-2 (181)
CNF 1 & 2 crude Yes + + ND (225)












Tvoe of Activitv/chances induced in cells
Bacterium and toxin purified gene
cloned















ETA purified Yes + ADP-ribosylate EF-2 (104)
Salmonella lyphi
LT-like enterotoxin crude Yes + + induces secretion (225)
Shigella dysenteriae 
Shiga toxin I & II purified Yes + ADP-ribosylate EF-2 (181)
Staphylococcus aureus 








induces secretion, acts as 
a superantigen





CT purified yes + elevates cAMP (61)
Yersinia enterocolidca












ND not determined; + = positive reaction; EF-2=elongation factor 2
to calculate the mol cGMP/cell, the cells were stained with trypan blue and counted on a 
hemacytometer and the cell numbers were adjusted so that an equal number o f test and 
control cells were assayed. Cells were lysed by the addition o f 25% HC1 and the resultant 
suspensions were centrifuged at 10,000 xg for 10 mm Supernatant fluids containing the 
cyclic nucleotides were removed for assay (51). The supernatants were incubated for 4 h 
at room temperature with a known amount o f 1125 labeled cGMP (Amersham) and this was 
followed by treatment with goat-anti rabbit cGMP antibody (Amersham) (51). The 
resulting cGMP-goat-anti rabbit cGMP antibody complexes were precipitated by the 
addition o f 80% isopropanol and the amount o f radioactivity in the pellets were 
determined on a gamma counter (Beckman Instruments, Inc., Irvine. CA). The amount of 
cGMP was expressed as moles o f cGMP/cell from a standard curve and using the formula 
below:
total counts/nrin 
total number of cells
4.3.2 Evaluation of protein synthesis.
C. jejuni cytotoxic filtrate was prepared as previously described in section 2.3.1. 
INT-407 cells were maintained in RPMI-1640 medium supplemented with 10 % FBS and 
100 U/ml penicillin and 100 pg/ml streptomycin. A total of 5x104 INT-407 cells/ml were 
seeded into a 96 well plate (Costar) and allowed to grow to about 50-70% confluency. 
Prior to the addition of cytotoxic filtrates, cells were washed three times with HBSS and 
the medium was replaced with RPMI-1640 supplemented with 10% FBS without 
antibiotics. A  total o f 100 pg of crude, concentrated filtrate from C. jejuni strain 2483 
were added to 5 wells each containing INT-407 cells and placed at 37°C in 5% C 02 for 23
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h. Five additional wells were tested with 100 p.g o f  crude concentrated filtrate from 
Corynebacteriitm diphtheriae ATCC strain 13812 as a positive control Pulsing media 
(containing 1 /2 0  o f  normal leucine levels) alone was used as the negative control to 
determine normal levels o f incorporation. After 23 h. the medium was removed from the 
cells and replaced with 200 pi pulsing media containing 2|iCi/ml o f L-[3H]-leucine 
(Amersham, Arlington Heights, IL) for an additional h at 37°C in 5% C 02. Cells were 
washed three times with HBSS to remove unincorporated L-[3H]-leucine.
The number of cells per well was determined as previously described (262) by first 
fixing the cells in absolute methanol for 10 min, followed by washing with HBSS, then 
staining for 30 min with 0.18% (wtv) safranin O at room temperature. Excess stain was 
removed by washing three times with HBSS and the cells were lysed by the addition of 
1% deoxycholate solution and the OD492 determined using an ELISA plate reader. A 50 
pi aliquot o f each o f the test and control wells were added to a vial containing 15 ml o f 
Ecohte scintillation fluid (ICN Pharmaceuticals Inc., Case Mesa, CA) and the amount of 
radioactivity per vial was determined using a scintillation counter (Beckman Scientific). 
The amount o f L-[3H]-leucine incorporation was determined from the formula below and 
expressed as percent of the control. Greater than 50% decrease in cellular protein 
synthesis was considered positive (37).
(ave. cpm of test wells/ ave. abs test well!
(ave cpm control wells/ave abs o f control wells)
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4.3.3 Effects of C  jejuni cytotoxic complex on host cell DNA.
HEp-2 and Vero cells were grown in T-75 cm2 flasks (Costar) in MEM and M 199 
media respectively each supplemented with 10% FBS. Twenty-four h. prior to 
intoxication, cells were subcultured into a 6-well plate (Costar) containing 3 ml of fresh 
media at a density o f SxlO4 cells. A total o f 5 pg o f cytotoxic protein/ml o f media was 
added to the cells for 24 and 48 h. Following incubation, the cells were treated with 
trypsin in order to remove them from the 6-well plate. Cellular debris was removed by 
layering on a Ficoll-hypaque gradient (Pharmacia Biotech) with a density o f 1.077 and 
centrifuging for 30 min at 500 x g. Cells at the interface were removed and washed twice 
in PBS. DNA was isolated from viable cells as described previously (232) by 
resuspending the pellet in 20 pi lysis buffer, incubating for 1 h at 50°C, and final 
incubation for 1 h at 50°C with 10 pi RNaseA (10 mg/ml) (Boehringer Mannheim). 
Subsequently, 10 pi o f 10 mM EDTA (pH 8.0) and 8 pi o f  6X sample buffer were added 
to the DNA mixture and the mixture heated to 70°C for 10 min prior to the loading of 
samples into the dry wells o f  a 2% agarose gel along with Hind lH digested lambda DNA. 
Gels were run for 5 min with buffer only in contact with the ends o f the gel before 
overlaying the entire gel with buffer and running to completion. Gels were stained with 
0.5 pg/ml ethidhun bromide (Sigma) and viewed on a transilluminator.
4.4 Results
4.4.1 Effects of cytotoxic filtrate on cellular processes.
Following intoxication o f INT-407 cells with C. jejuni cytotoxic filtrate, cellular 
cGMP levels and protein synthesis capabilities were measured by radio-immunoassay and 
incorporation o f L -[^ -leucine  respectively. The unintoxicated control ENT-407 cells in
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the cGMP level determination assay were found to contain 2.63 X 1 O'20 mol cGMP/cell 
while intoxicated cells contained 2.7 XIO'20 mol cGMP/cell (Fig 4.1).
The effects o f  filtrate on host cell protein synthesis was based on the average of 
five wells for each o f  the control and test wells and was expressed as a percent of normal 
protein synthesis present in the control cells (Fig 4.2). Cells intoxicated with C. jejuni 
cytotoxic filtrate gave 16% of the protein synthesis activity as compared to the unaffected 
control. The positive control cells intoxicated with diphtheria toxin, possessed 13% of 
normal protein synthesis as compared to the control Since readings greater than 50% 
decrease in incorporation are considered significant (37) and since the control diphtheria 
induced a reduction of 87% in protein activity, the reduction o f  84% resulting from C  
jejuni indicated that the toxin significantly affected host cell protein synthesis.
4.4.2 Effects of cytotoxic porin-LPS complex on cellular DNA.
Qualitative analysis o f the effects elicited by the purified cytotoxic complex 
produced by C. jejuni on cellular DNA are shown in Fig 4.3. The results showed that the 
complex induced DNA fragmentation in HEp-2 cells as early as 24 h following 
intoxication as compared to control DNA. Vero cell DNA was unaffected by the 
cytotoxic complex at both 24 and 48 h. The cytological changes elicited by the complex in 
HEp-2 cells were typical of the effects induced by the isolated porin-LPS complex (section 
2.4.1). However, intoxicated Vero cells lacked vacuole formation, cytoplasmic blebbing, 
nuclear condensation and rounding which were characteristic o f  the progression of the 
cytotoxic activity observed in HEp-2 cells.
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Figure 4.1
Effects on the cellular levels o f cGMP of 100 fig crude, concentrated cytotoxic 
filtrate from C. jejuni, strain 2483 on INT-407 cells after 24 h intoxication. The amount 
of cGMP was determined by RIA and calculated from a standard curve using known 
concentrations o f cGMP and expressed as mol cGMP/ celL
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
125
|  control
C. jejuni cytotoxic filtrate
C. diphthe riae cytotoxic 
filtrate
Figure 4.2
Effects o f the cytotoxic filtrate from C. jejuni, strain 2483, on INT-407 cell protein 
synthesis. The amount o f  L-[3H]-leucine incorporated in nascent proteins was an average 
of 5 test wells and expressed as a percent of the control Less than 50% decrease in 
protein synthesis as compared to the control was considered significant. Control INT-407 
cells: unintoxicated; C. jejuni cytotoxic filtrate: INT-407 cells were intoxicated with 100 
(ig crude filtrate from C. jejuni, strain 2483; C. diphtheriae cytotoxic filtrate: INT-407 
cells intoxicated with 100 pg crude filtrate from Coryiiebacterium diphtheriae ATCC 
strain 13812.
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Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Figure 4.3.
Effects on HEp-2 and Vero cell chromosomal DNA of C. jejuni 2483 isolated 
porin-LPS complex. Lane 1 and 8: HindUl digested lambda DNA; lane 2 Control 
unintoxicated HEp-2 cell DNA; lane 3: HEp-2 cells DNA following intoxication with 5 
pg/ml o f C. jejuni cytotoxic complex for 24 h; lane 4: HEp-2 cells DNA following 
intoxication with 5 pg/ml o f C. jejuni cytotoxic complex for 48 h; lane 5: Control 
unintoxicated Vero cell DNA; lane 6: Vero cell DNA following intoxication with 5 |ig/ml 
of C. jejuni cytotoxic complex 24 h; lane 7: Vero cell DNA following intoxication with 5 
pg/ml o f C. jejuni cytotoxic complex for 48 h.
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4.5 Discussion.
Little is known regarding the mode o f action o f  exotoxins produced by C. jejuni. 
Everest et al. (62) reported an elevation o f leukotriene B4, prostaglandin and cAMP in 
rabbit ileal loops following infection with some strains o f  C. jejuni which was similar to 
that produced by V. cholerae and E. coli heat-labile enterotoxin. C. jejuni has also been 
shown to produce heat-stable or labile alpha- and beta-hemolytic toxin (62, 99). 
Preliminary experiments using purified C. jejuni cytotoxin failed to lyse chicken, horse or 
rabbit erythrocytes in vitro under physiologic conditions (personnel communication with 
C. Clark). Misawa et aL (162) documented visible hemolysin production by certain strains 
o f C. jejuni when grown on 5% sheep blood agar. However, the strain o f C. jejuni used 
in the purification o f  the cytotoxic protein did not produce a visible hemolysin when 
grown on tryptic-soy agar plates containing 5% sheep blood for 48 h.
Other exotoxins produced by Campylobacter spp. and closely related organisms 
have been reported (79, 225, 257). The most characterized to date is the vacuolating 
cytotoxin produced by Helicobacter pylori (48) but its molecular weight, purification 
characteristics and amino acid composition appears quite distinct from the purified C. 
jejuni cytotoxic protein described in these studies. However, as stated earlier, at the onset 
o f cytotoxicity in HEp-2 cells, vacuoles form in the cytoplasm of intoxicated host cells and 
these appear similar to those induced by the vacuolating cytotoxin o f H. pylori (48, 247). 
Vacuole formation by H pylori cytotoxin can be reversed in vitro by the addition of V- 
type ATPase inhibitors and potentiated by inhibitors o f Na+-K+ ATPase (247). This 
suggests that the mechanism o f action of the H. pylori cytotoxin is due to atypical cation
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transport within host cells (247). The effects o f  ATPase inhibitors on the formation of 
vacuoles induced by C. jejuni cytotoxic complex still remains to be elucidated.
Another toxin produced by a related species Wolinella (Campylobacter) rectus has 
been partially purified and characterized (79). The molecular weight is in excess o f 100 
kDa and the N-terminal structure suggests that it is similar to the leukotoxin produced by 
Actinobacillus actinomycetemcomitans. The N-terminal sequence o f the cytotoxic protein 
purified from C. jejuni does not share homology with known leukotoxins (section 2.4.2) 
but like the leukotoxin produced by A. actinomycetemcomitans, the cytotoxic material 
from C. jejuni is closely associated with LPS. A leukotoxin has been described as being 
produced by C. jejuni, but it has yet to be purified and characterized (129).
Elevation o f cyclic nucleotides (cGMP and cAMP) are well characterized effects 
o f  enterotoxins (138). Unlike the heat-stable enterotoxin produced by E. coli (51), C. 
jejuni cytotoxic filtrate failed to increase cellular levels of cGMP. Enterotoxins (CT and 
LT) also caused CHO cells to become elongated when intoxicated, but eventually the cells 
revert back to their normal shape since cytotonic enterotoxins do not induce permanent 
morphological changes in these cells. Cytotoxins are readily distinguishable from 
enterotoxins in cell culture assay as they cause cells to round up and become highly 
refractde. Unlike the reversible action o f enterotoxins, cytotoxin treated cells do not 
recover following intoxication (225). Cells exposed to the C. jejuni cytotoxic protein, 
showed no elongation but rather the permanent rounding typical o f a cytotoxic response. 
Previous studies by Johnson et a/.(108) showed that toxic filtrates from C. jejuni caused a 
1-1.3-fold increase in cAMP depending on the strain tested while cholera and E. coli LT 
caused 85-180-fold increases in cAMP (108). As a consequence of these findings, the
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effects on host cell processes dicited by known cytotoxins were investigated in greater 
detaiL
The experiment using L-f3!!]-leucine was designed to determine the effects o f C. 
jejuni cytotoxin on cellular protein synthesis and the results showed a significant decrease 
in incorporation o f  a radio-labeled amino acid following intoxication. Further studies are 
required to determine if  the cytotoxin induces holes in the cell membrane similar to 
Staphylococcus aureus a-toxin permitting the release of Mg2+/Ca2+ which are vital for 
normal cellular processes. Other experiments, such as in vitro transcription/translation 
techniques using rabbit reticulocytes, can be used to determine if the cytotoxin directly 
effects protein synthesis. However, this experiment cannot distinguish between 
inactivation o f the ribosomes and ADP-ribosylation o f  elongation factor-2 (46, 211). 
Studies using C14 labeled NAD* and elongation factor-2 can be used to distinguish 
between the two steps (46).
Apoptosis, or programmed cell death, is involved in maintaining the proper number 
o f cells during development and for homeostasis (45). Several mechanisms, such as the 
generation o f nitric oxide, protease production and the release of Ca2+ from the 
mitochondria are involved in the apoptotic process (45, 212). The cytotoxic complex 
from C. jejuni elicits cytological changes in host cells in a similar manner to verotoxin type 
1, which also induces apoptosis but in Vero cells (105). Inhibition of protein synthesis, 
either by inactivating the 60 S ribosome as effected by verotoxin and shiga toxin (181,
211) or ADP-ribosylating elongation factor-2 as induced by diphtheria toxin (46) have 
been shown to induce apoptosis as well (105). Inhibition of DNA synthesis could also be 
caused by the release ofM g2+/Ca2+ from intoxicated cells. The inhibition of de novo DNA
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synthesis by the addition o f the transcription inhibitor actinomycin D has also been shown 
to induce apoptosis (198). Recently, Shiga toxin has been shown to induce nitric oxide 
production in macrophages but whether or not this leads to apoptosis was not determined 
(274).
Since the C. jejuni cytotoxic complex was unable to induce DNA fragmentation in 
Vero cells and had very little cytotoxic effects on these cells, the results suggest that the 
receptors specific for binding the cytotoxin are more prevalent on the surface o f HEp-2 
than Vero cells. The nature of the cytotoxin is not known but preliminary results, in 
conjunction with Dr. Glen Armstrong at the University of Edmonton, Alberta, Canada, 
suggest a ganglioside similar to GMi (personal communication with G. Armstrong). 
However, the receptor was found to be quite distinct from the verotoxin receptor Gb3 
(globotriaosylceramide) (7, 181).
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C. jejuni has been shown to produce several unique exotoxins (225, 257). The 
toxins have been found to be either heat-labile (85, 109, 150) or heat-stable (143) and are 
either sensitive or resistant to degradation by trypsin (85, 150). C. jejuni, is a gram 
negative organism and hence expresses LPS, a potent endotoxin; however, there have 
been no reports regarding the possible role of the LPS in toxicity. In the present study, a 
cytotoxic complex has been detected and found to be associated with an isolated bacterial 
fraction rich in LPS.
The sequence data obtained from the protein component of the cytotoxic complex 
showed that it was similar to the porin protein isolated from the outer membrane of C. 
jejuni strain 85H (26) as well as the membrane proteins from W recta (117). However, 
the only reported information regarding the C. jejuni porin concerns its pore forming 
capabilities (103) and the fret it has been classified as a member o f the microbial trimeric 
porin family (26). SDS-PAGE using isolated denatured porin protein preparations 
showed it to posses a molecular weight o f approximately 45 kDa (26, 103) and to have a 
pi o f4.35 (26). The data presented here confirmed these finding for molecular weight and 
pL The production o f an apoptotic, porin-LPS complex produced by C. jejuni as well as
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certain related organisms may explain why the cytotoxin, known to be produced by these 
organisms, has proved so elusive. Indeed, several reports have documented the presence 
o f  a cytotoxin but until now there has been no information on the N-terminal sequence. 
Published accounts offer speculative determinations o f cytotoxic proteins o f a variety of 
sizes (85, 166) and this has made it difficult to formulate accurate comparisons between 
cytotoxins. However, Guerrant et al (85) reported the production and characterization of 
a heat-labile and mildly trypsin-sensitive protein with a molecular mass greater than 14 
kDa as determined by gel filtration column chromatography. They also indicated that the 
cytotoxic activity could not be neutralized with anti-Shiga-like toxin (verotoxin) (85).
This was contrary to a report by Moore et al. (167) in which the production of a Shiga- 
like cytotoxin from C. jejuni was documented. In the present study, results regarding the 
isolated porin-LPS showed that toxicity was heat-labile, was resistant to trypsin 
degradation and produced characteristic morphological changes in cells in culture similar 
in appearance to those induced by verotoxin; however, these could not be neutralized with 
antisera against either E. coli VT1 or VT2. Also, PCR experiments using primers specific 
for E. coli VT1 and VT2 M ed  to produce amplicons suggestive o f similar intact 
verotoxin genes.
The nature and the timing of morphologic changes induced in various cell cultures 
by the porin-LPS complex appeared to be dose dependent. At the higher concentration of 
10 |ig o f protein/cell culture well, vacuoles were formed rapidly but these dissipated 
within the first 12 h after intoxication. By 48 h after intoxication, 80-100% of the cells 
appeared rounded and refractile. At the lower concentration of 1 pg o f  protein/cell
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culture well, the vacuoles persisted for up to 48 h post-intoxication and the rounding and 
refractile nature o f  the cytotoxic changes become more apparent at 72 h. On careful 
examination, the vacuoles have an appearance similar to those produced by H. pylori in 
affected cells(50). PCR experiments using primers specific for the vacA and cagA genes 
failed to produced amplicons and suggested that neither o f these genes were present in C. 
jejuni. The purified vacuolating cytotoxin from H. pylori has a molecular weight of 87 
kDa when examined under denaturing conditions (49); almost twice the molecular weight 
o f the porin found in C. jejuni.
The carbohydrate component of the LPS was characterized using a series o f lectins 
conjugated to alkaline phosphatase. The positive results with the lectins Galanthus nivalis 
agglutinin (GfNA), Maackia amurensis agglutinin (MAA) and Datura stramonium (DSA) 
indicated that the carbohydrate possessed terminally linked mannose and sialic acid 
terminally linked a(2-3) to galactose as well as galactose-P( l-4)-N-acetylglucosamine 
complexed together with hybrid N-glycan structures (see Table 2.1). The Penner 
serotyping scheme for Campylobacter is based on the heat-stable 0  antigen of the 
organism and strain 2483 was found to be 0:11. It is unfortunate that currently there is no 
information regarding the carbohydrate composition o f the LPS from this serotype; 
however, the positive lectin results suggested that LPS from 0 : 11 was similar to that for 
serotypes 0 :2  and 0 :4  (10,11). Infections with these serotypes which have been 
implicated in Guillain-Barre syndrome (GBS). GBS is a severe degenerative neurological 
autoimmune disease which is thought to occur due to the molecular mimicry that exist 
between the LPS from certain strains o f C. jejuni and the gangliosides present on human
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nerve cells (8,27"’). It is speculated that infections with certain serotypes o f C. jejuni 
possessing ganglioside-like molecules enhance an immune response directed against 
ganglioside GMi, GDu, GDu> and GTib present on the human nerve cells leading to 
demyelation. GBS can be a long term debilitating disease and in some instances may be 
life threatening which has led to an increase in the mortality and morbidity rates associated 
with cases o f  campylobacteriosis.
Toxicity of the porin-LPS complex was found to be associated with the protein 
component. This critical finding was confirmed using several methods: 1) the most 
convincing was that the toxicity o f the complex was heat-labile at 70°C for 30 min; 2) 
attempted degradation o f the cytotoxic complex using the enzymes neuriminidase and 
glycosidase F each o f which target the structures identified with the lectins MAA and DSA 
respectively were to no effect; 3) oxidation of the carbohydrate component o f the porin- 
LPS complex with 10 mM sodium meta-periodate also had no effect on toxicity when 
tested in HEp-2 or HeLa cells. Since toxicity was maintained following oxidation and 
glycosidase treatments, adherence of the complex to host cells is most likely mediated via 
the porin component. These findings are contrary to a previous report (154) in which it 
was stated that LPS was involved in adherence o f the organism to HeLa cells and that this 
property was lost following oxidation with sodium meta-periodate. Yet another report 
(66) indicated that the porin was not involved in adherence to HeLa cells.
As shown in the present study, using Giemsa staining o f intoxicated cells, the 
porin-LPS complex was able to induce DNA fragmentation in HEp-2 cells but not in Vero 
cells. This fragmentation is characteristic o f cells that are in the process of becoming
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apoptotic. Furthermore, cytoplasmic blebbing and nuclear condensation are also common 
characteristics o f cells undergoing apoptosis (45,212). HEp-2 cells intoxicated with the 
porin-LPS complex from C. jejuni strain 2483 showed cytoplasmic blebbing and nuclear 
condensation effects typical o f  apoptosis. Similar findings have been reported for VT1, an 
apoptotic cytotoxin from f. coli (105). The effects o f crude concentrated bacterial-cell- 
free filtrate from C. jejuni 2483 containing the porin-LPS cytotoxic complex was also 
found to significantly effect the ability o f  human INT-407 cells to incorporate ^-leucine 
in nascent peptides. However, the cytotoxic filtrate had no effect on cGMP levels, a well 
reported mode o f action for the E. coli heat-stable enterotoxin (51, 224).
Inhibition o f protein synthesis by bacterial toxins has been shown to lead to 
apoptosis in affected cells (45). E. coli verotoxin and C. diphtheriae toxin are two 
examples of cytotoxins that induce apoptosis by the inhibition of protein synthesis (45). 
Since, the porin-LPS complex from C. jejuni was found to be distinct from E. coli VT1, it 
may act in a manner similar to S. aureus a-toxin which induces apoptosis by creating holes 
in affected host cell membranes leading to the release of Mg2+, Ca2+ and other components 
vital to cell function. The complex described in this study may function by inserting itself 
into host cell membranes creating a functional porin similar to that present in the outer 
membrane o f C. jejuni (26, 103). The porin from C. jejuni UA580 was found to form a 
small cation selective channel (103) which could facilitate the release ofM g2+ and Ca2+ 
from intoxicated cells.
Purified porins have been shown to be cytotoxic to host cell and serve as adjuvants 
for enhancing immune responses (23, 54, 76, 77). Porins from S. typhimurium have been
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shown to act specifically on the cytoskeleton ofHEp-2 cells (54) while porins from 
Neisseria inhibit actin polymerization as well as degranulation, opsonin receptor 
expression and phagocytosis in neutrophils (23). Either method may serve the organism 
and assist it to escape the protective capabilities o f the host’s defence system. In addition,
S. typhimurium porins independent o f LPS are capable o f inducing an inflammatory 
response in rat paws (77). In these animals, histamine release from rat peritoneal cells was 
dose dependent as was the development o f edema which reached a peak response 2 to 3 h 
after porin injection. However, edema was markedly reduced if  the rats were first treated 
with anti-histamines but not if  the rats were decomplemented (77). This shows that porins 
are capable o f inducing edema leading to an inflammatory response independent of the 
complement system (77). Based on the cytotoxicity and inflammatory responses elicited 
by porins, it is clear that they should be considered bacterial virulence factor per se (54, 
513, 77).
The porin-LPS complex may not be produced by the organism in response to 
adverse conditions encountered by the organism The cytotoxicity elicited by the porin- 
LPS is most likely accidental and may be a by-product o f cell growth and death (513).
The porin from C. jejuni may serve two functions: 1) to allow for the exchange of 
material between the environment and the organism (103, 176); and 2) to serve as a 
method which permits the organism to survive better in the environment within the host as 
it becomes less favorable by releasing nutrients from host cells in the gut (156) or when it 
is acted upon by the defense system The porin-LPS structure may oligomerize in the
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membranes and form small cation-selective channels in much the same way as the 
hemolysin HlyA produced by V cholerae forms anion selective channels (156).
The sequence data obtained from the N-terminal o f the isolated protein was used 
to construct oligonucleotides which were subsequently used with a combination of 
vectorette PCR (213), inverse PCR and cloning to  sequence the porin gene. The detected 
and sequenced gene was designated porA. The porA gene consisted o f a 1275 bp ORF 
which encoded a protein consisting o f424 amino acid. This had a molecular weight of 
45.6 and a p i o f  4.44. The %G+C content was found to be 36.7 mol % which was slightly 
higher than previously described by Taylor et al (246). This increase in %G+C may 
explain why certain codons were used more frequently than those previously described in 
a compilation table available through Genbank. The mature protein contained a 22 amino 
add protein which was cleaved prior to insertion yielding a final protein component with a 
molecular mass o f 43.5 kDa and a pi o f 4.35 and this was similar to that previously 
described (103, 26). The gene contained a typical Shine-Dalgamo sequence and a 
previously published -35 region (199) and a putative -10 site. There was also a strong 
rho-independent transcription termination sequence (4) which consists of a 9 bp dyad 
separated by a 5 bp loop and a poly T region immediately distal to the stem of the loop.
Comparative analysis o f the ORF using BLAST showed it had the largest 
homology with H. influenzae P2 DNA (91) over short stretches and a 50% sequence 
similarity but only a 23% sequence identity with the translated P2 protein. PorA also had 
significant sequence similarity with Enterobacter cloacae PhoE, K. pneumoniae PhoE, S. 
typhi OmpC and E. coli PhoE even though sequence identity was low. Sequence
134
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
similarity can be used to help define the functionality o f the PorA protein compared to 
other well known porins and may also be used to compare the secondary structures as well 
(176).
The relative amounts o f basic, polar and acidic residues are similar to that of H. 
influenzae P2 and the enterobacterial consensus sequence but the present study showed 
that there are a greater frequency o f hydrophobic residues in the porin from C. jejuni. The 
molecular weight o f  H. Influenzae P2 is 39.7 kDa while the enterobacterial consensus 
sequence is approximately 35 kDa. Since PorA is larger, it is not surprising that it 
contains more hydrophobic residues which may result from greater concentrations of 
intra-membrane (3-pleated sheets. This is evident when the hydrophobic and beta sheet 
charts from these three porin, calculated by the method of Novotny (179), were 
compared. C. jejuni PorA was estimated to contain 12 membrane spanning domains as 
compared to 8 for the enterobacterial consensus sequence and Rhodobacter capsulatus 
porin (176).
5.2 Conclusions
The identification and characterization of the cytotoxic effects elicited by the major 
outer membrane porin protein from C. jejuni had not been documented prior to these 
studies. The close association maintained between the porin protein and the LPS made the 
complex difficult to isolate and this may offer an explanation as to why the cytotoxin 
known to be produced by C. jejuni has been so difficult to describe. The DNA sequencing 
of the porA gene allows for more comprehensive studies in the future, in particular with 
respect to the role PorA protein plays in campylobacteriosis. Cloning and expression of
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PorA may also lead to a possible recombinant vaccine. A recombinant vaccine could 
lessen the severe and sometimes fatal sequelae associated with C. jejuni infections 
permitting a reduction in overall health costs.
In conclusion, C. jejuni is an enteric pathogen that can induce a severe form of 
gastroenteritis resulting in dysentery or blood and mucus in the stooL From these studies 
it is postulated that the disease induced in humans by C. jejuni is due to the cytotoxic 
effects on host cells in the gut arising from the expression of the porA gene and that the 
PorA porin-protein product influences host cell protein synthesis. This damage 
contributes to the symptoms observed in campylobacteriosis.
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APPENDICES
Appendix 1: Biological studies
A. Bacterial cultivation and storage.
1.1 C. jejuni strain 2483 was passed once prior to the beginning of the study and was
maintained at -80C on trypic soy broth supplemented with 5% sheep blood. 
Virulence was assessed after passage by the fertile hens egg model (150).
1.2 5% Blood agar plates
Blood agar plates were prepared adding 25 ml sheep blood to 475 ml sterile 
tryptic soy agar which had been autoclaved and allowed to cool to about 50 °C 
prior to the addition o f the blood. Plates were poured and allowed to cool 
overnight at room temperature.
1.3 Glycerol Peptone water
The strains o f bacteria obtained from the Laboratory Centre for Disease Control in 











The solution was adjusted to a pH o f 7.0 then autoclaved in 15 ml aliquots and
stored at 4 0 C until needed.
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B. Cell culture
1.4 Hanks Balanced Salt Solution (HBSS)
Sterile batches o f 500 ml lOx concentrated solution was purchased from Sigma 
Chemical Company. A total of 50 ml o f sterile HBSS was added to 450 ml sterile 
ddH20 and the pH  was adjusted with sterile Na2HCC>3. The solution was stored at 
4 °C until needed.
1.5 Sodium bicarbonate
A 7.5% solution o f Na2HC(>3 was prepared by adding 7.5 grams of Na2HC03. 
to 100 ml ddH20 then filter sterilized using a 0.22 |xm syringe filter. The stock 
solution was stored at 4°C until needed.
1.6 Sodium hydroxide
A IN NaOH solution was made by adding 4 g NaOH pellets to 100 ml ddH20 and 
sterilized by autoclaving.
1.7 Fetal Bovine Serum
Sterile fetal bovine serum was purchased from Sigma Chemical Company and 
aliquoted into 25 ml batches and stored at -20 °C until needed.
1.8 lOx Phosphate buffered Saline (PBS)
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Hie buffer was pH  to 7.0 with 10 N NaOH and diluted 10-fold prior to use with 
ddH20 .
1.9 Minimal essential media (MEM)
HEp-2, HeLa and CHO cells were maintained in MEM supplemented with 10 % 
FBS. Sterile 10 x MEM was purchased from Sigma Chemical company and 500 
ml batches o f media were prepared by.
Component Amount




7.5 sodium bicarbonate 5 ml
The media was adjusted to pH 7.2 with sterile 10 N NaOH was sterility tested by 
plating an aliquot to both a nutrient and blood agar plate.
1.10 RPMI-1640
INT-407 cells were maintained in RPMI-1640 media supplemented with 10 % 
FBS. Sterile 10 x RPMI-1640 was purchased from Sigma Chemical company and 
500 ml batches o f media were prepared by
Component Amount




7.5 sodium bicarbonate 5 ml
The media was adjusted to pH 7.2 with sterile 10 N NaOH was sterility tested by 
plating an aliquot to both a nutrient and blood agar plate.
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1.11 Tiypsm-EDTA (0.05% to 0.02%)





Ca+ and Mg* free saline 500 ml
phenol red 50 mg
The solution was filter sterilized with a 0.22 pm filter and in 25 ml aliquots at
-20°C until needed.
Appendix 2: Molecular Biology studies
A. Protein analysis
2.1 Lower gel buffer




ddH20  was added to final volume o f 1 L and the pH adjusted to 8.9. The solution
was stored at 4°C  until needed.
2.2 Upper Gel buffer
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ddH20  was added to final volume o f 1 L and the pH adjusted to 6.8. The solution 
was stored at 4°C  until needed.
2.3 2 x  SDS sample buffer






1% Bromophenol blue 1 ml
ddH20  was added to final volume o f 1 L and the pH adjusted to 6.8. The solution
was stored at room temperature until needed.
2.4 30% SDS slab aciylamide




ddH20  was added to final volume o f 1 L and the solution was stored at 4 ° C until
needed.
2.5 10 x Running Buffer
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ddH20  was added to final volume o f 1 L. The buffer was diluted to IX with 
ddH20  before use.
2.6 Western transfer buffer.
10 x SDS-PAGE running buffer was used for Western transfer with the addition o f 
20 % methanol to the 1 x working solution.
2.7 10% Ammonium Sulfate
Ammonium sulfate was prepared as follows:
Component Amount
ammonium sulfate 1 g
ddH20  9.4 ml
lml aliquots were stored at -20 °C until needed.
2.8 Coomassie Brilliant Blue R-250 stain (0.125%)
Coomassie blue was prepared as follows:
Component Amount
Coomassie Brilliant Blue R-250 1.25 g
methanol 50%
glacial acetic acid 7%
ddH20  to one liter
The stain was filtered using Whatmann filter paper and stored at room
temperature.
2.9 Destain for Coomassie Brilliant Blue R-250 stain 
Destain was prepare a follows:
Component Amount
methanol 50%
glacial acetic acid 7%
ddH20  to one liter
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The solution was stored at rom temperature.
B. Agarose gel electrophoresis
2.10 6X sample buffer





dcLH^O was added to a final volume o f 50 ml and the solution was stored at room 
temperature.
2.11 10X Tris-acetate, EDTA (TAE)




glacial acetic acid 0.2 M
















ddH20  was added to 1 L and the pH adjusted to 7.0. The stock was diluted with 
ddH20  to desired concentration prior to use.
Denaturing solution




ddH20  was added to 1 L.
Neutralizing solution




ddH20  was added and the pH adjusted to 7.5.
Hybridization solution




EDTA 0.01 M, pH 8.0
Denhardt’s solution 5 x
SDS 0.5 % (w/v)
sheared denature,
salmon sperm DNA 100 pg/ml
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The hybridization solution was aliquoted into 10 ml tubes and stored at -20 ° C 
until needed.
2.15 10 X low salt Tris-buffered saline (TBS)




ddH20  was added to  a final volume o f 1 L and the pH adjusted to 7.0.
2.16 Washing buffer
Washing buffer was prepared as follows:
Component Amount
Tris-HCL, p H  9.5 0.1 M
NaCl 0.1 M
MgCl2 50 mM
This solution was used to equilibrate the membranes to the proper pH and MgCl2 
concentration prior development with either CPD-star or BCIP and NBT.
D. Polymerase chain reaction
2.17 PCR reaction buffer




Triton X -100 1%
MgCfe 30 mM
ddH20 was added to a final volume of 100 ml and the pH was adjusted to 8.3.
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2.18 10 x Dinucleotide diphosphates (dNTP’s)
dNTP’s were purchased from Sigma Chemical Company and reconstituted to a 
concentration o f 200 pM o f each dATP, dGTP, dCTP, d i 1’P. 1 ml aliquots were 
stored at -20 °C until needed.
2.19 PCR reaction mixture
PCR reaction mixture was prepared as follows:
Component Amount
primers 1 pM each
dNTP’s mixture 200 pi
10 x PCR reaction buffer 100 pi
Taq DNA Polymerase (5 units/pl) 22 pi
Sterile ddU O  was added to a final volume o f 1000 pi and was stored at -20 °C
until needed. Taq DNA polymerase was purchased from Promega in 20 pi
aliquots and was stored at -20 °C until needed.
C. Mode of action studies 
3.1. Pulsing media
Pulsing media was used in the protein inhibition studies and prepared as indicated 
below:
Component Amount
10 x HBSS 10 ml
10X RPMI-1640 0.5 ml
(1/20 o f normal leucine concentration)
2pCi/ml L -f^-leucine
dcfflbO to 100 ml
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The radioactive leucine was added prior to use and only the amount required to 
perform the experiments was prepared
3.2 Lysis buffer
The cells evaluated for DNA fragmentation were lysed by the addition of a buffer 
containing:
Component Amount






A 50 ml stock solution was prepared and stored at room temperature until
required.
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